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CHARACTERIZATION OF A MURINE GAMMAHERPESVIRUS IN VITRO 
LATENCY SYSTEM 
Kudakwashe Mutyambizi, Yale University School of Medicine (Sponsored by Michael 
Kashgarian, Department of Pathology, Yale University School of Medicine, and Stacey 
Efstathiou, Department of Pathology, University of Cambridge) 
The human gammaherpesviruses EBV and KSHV realize their oncogenic potential 
during latent infection. The species specificity of the human gammaherpesviruses has 
hindered the study oflatency in animal models. Murine gammaherpesvirus MHV-68 
(MHV-68) may be used as a representative gammaherpesvirus for the study of latency. 
The goal was to establish an in vitro model of MHV -68 latency using replication 
defective MHV-68. ORF50 has been identified as the major viral trans-activator essential 
for entry into the lytic replication cycle and necessary and sufficient for reactivation of 
MHV-68 virus from latency. ORF50 null mutants (£;,50) can theoretically be used to 
infect cells in vitro to facilitate an analysis of virus gene expression and episome 
maintenance during latency. In this project £;,50 mutants containing the luciferase or 
green fluorescence protein (GFP) under ORF50 promoter control were used to infect a 
variety of cell types. 3T3 fibroblasts are a permissive cell line and were used for an initial 
characterization of the ability of £;,50 MHV-68 to establish latency. B lymphocytes and 
macrophages are the major reservoirs of persistence in vivo thus the ability of £;,50 
mutants to establish latency in NSO B and RAW macrophage cell lines was explored. 
Latency was readily established and maintained in 3T3 and RAW cells.The low 
infectability ofNSO B- cells restricted the utility of this cell line in studies oflatency. 
Examination of patterns oflytic and latent transcription in 3T3 and RAW cells co-
ordinately infected with £;,50 MHV -68 revealed reactivation efficiencies of 40-60%. 
Following long-term passage 6.50 exhibited stable transcription of two latency related 
genes M2 and ORF73, with episomal maintenance of the viral genome, in the absence of 
contaminating lytic infection. The results demonstrate the utility of 6.50 mutants for 
studies of gammaherpesvirus latency in vitro. 
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ABSTRACT 
The gammaherpesviruses have in common the ability to establish latency in infected 
hosts. The species specificity of the human gammaherpesviruses has hindered their study 
in animal models. Murine gammaherpesvirus MHV-68 (MHV-68) efficiently infects the 
laboratory mouse providing a representative gammaherpesvirus for the study of latency. 
The goal was to establish an in vitro model ofMHV-68 latency using replication 
defective MHV -68. ORF50 has been identified as the major viral trans-activator essential 
for entry into the lytic replication cycle and necessary and sufficient for reactivation of 
MHV-68 virus from latency. ORFSO null mutants (~50) can theoretically be used to 
infect cells in vitro to facilitate an analysis of virus gene expression and episome 
maintenance during latency. In this project ~50 mutants containing the luciferase or 
green fluorescence protein (GFP) under ORF50 promoter control were used to infect a 
variety of cell types. 3T3 fibroblasts are a permissive cell line and were used for an initial 
characterization of the ability of ~SO MHV -68 to establish latency. In addition since B 
lymphocytes and macrophages are the major reservoirs of persistence in vivo the ability 
of ~SO mutants to establish latency in NSO B and RAW macrophage cell lines was 
explored. Latency was readily established and maintained in 3T3 and RAW cells. In 
contrast the low infectability ofNSO B- cells restricted the utility of this cell line in 
studies oflatency. Examination of patterns oflytic and latent transcription in 3T3 and 
RAW cells co-ordinately infected with ~50 MHV -68 revealed reactivation efficiencies of 
40-60%. Following long-term passage ~SO exhibited stable transcription of two latency 
related genes M2 and ORF73, with "pisomal maintenance of the viral genome, in the 
absence of contaminating lytic infection. The results demonstrate the utility of ~SO 
mutants for studies of gammaherpesvirus latency in vitro. 
CHAPTER 1 
1 
INTRODUCTION 
The Herpesviridae 
The herpesviridae are a family of viruses classified according to their characteristic virion 
architecture. The virions consist of a single linear double stranded DNA molecule packaged 
within an icosahedral capsid, ranging from 100-llOnm in diameter [Roizman et aI, 1991). 
Surrounding the capsid is the poorly defined tegument layer, containing viral proteins, some of 
which are necessary for virion formation. Closely attached to the outer tegument surface is a 
membrane envelope resembling the cellular Golgi membrane, and containing immunogenic viral 
glycoproteins [Fields et aI, 2001). 
The herpesviruses have evolved from a common ancestor, but have diverged widely, with 
branchings of their phylogenetic trees reflecting those of their mammalian hosts as they co-
evolved. On the basis of variation in genomic arrangements, gene content and biological 
attributes, the herpesvirues have been subdivided into the Alpha-, Beta- and Gammaherpesvirus 
subfamilies [McGeoch et aI, 2000). 
2 
Alphaherpesvirinae 
The alphaherpesviruses are grouped together based on their biological properties and sequence 
similarities [International Committee on Taxonomy of Viruses, 2000] . As a general rule, 
members of this family infect epithelial cells productively, have a short reproductive cycle with 
efficient destruction of infected cells, and have the tendency to establish latent infection 
primarily although not exclusively in sensory ganglia. 
Betaherpesvirinae 
In contrast to the alphaherpesviruses, members of this subfamily tend to be species specific and 
cell type specific in culture. The reason for host restriction is not clearly understood, although 
cell surface receptors have been implicated [Huemer et aI, 1995]. Often viruses can enter a 
variety of cells but intracellular factors limit susceptibility. The betaherpesvirus growth cycle is 
characteristically slow, the virus remaining cell associated, with cytomegalia frequently 
occurring. Infection is rarely clinically apparent in immuno-competent individuals, with disease 
manifesting in any organ in the immuno-suppressed. 
3 
Gammaherpesvirinae 
Members are included on the basis of overall co-linearity and genomic organisation. Infectivity 
is restricted to the natural host, and latent in vivo infection occurs in lymphocytes with some 
members also able to Iytically infect some types of epithelioid and fibroblastic cells [Roizman et 
al. 1991). Acute infection frequently results in Iymphoproliferative disorders and both lymphoid 
and non lymphoid malignancies are associated with many members of this subfamily 
[Ackermann 2006). 
The gammaherpesvirinae are further subdivided into the genus lymphocryptovilUs or 
rhadinovilUs. The lymphocryptovilUses have only been found in primates. Members contain 
homologues of the EBNA genes of Epstein Barr VilUs (EBV). B lymphocytes are infected by 
these viruses in culture, and are latently infected in vivo. Infection ofB lymphocytes in culture is 
generally non productive, but can lead to immortalization. 
Members of the rhadinovirus genus are able to productively infect fibroblasts of multiple species, 
and have been isolated from a wide range of mammalian species. 
Latent infection has been identified in T and B lymphocytes. Kaposi's Sarcoma Related Herpes 
, 
Virus (KSHV) and MHV -68 are rhadinoviruses infecting B cells, while HVS infects T cells. 
4 
Table I 
The human herpesviruses are listed according to type, cell tropism and site oflatent infection. 
The mode of transmission is known for all the human herpes viruses, with the exception of 
HHV -7. Adapted from pathmicro.med.sc.edu/virollherpes.htmIReferences: [Kumar et ai, 2005] ; 
[Sheridan et ai, 2007] ; [Sinclair et ai, 2006] ; [Cesarman et ai, 1996]. 
iauman 
Name ~arget Mode of iaerpes Subfamily cell Site of 
~ype type fLatency Transmission 
1 Herpes simplex ~lphaherpesvirinae ~ucoepithelia ~eurons Close contact 
- 1 (HSV- l) 
2 Herpes simplex ~lphaherpesvirinae ,"ucoepi thelia fNeurons Close contact 
-2 (HSV-2) usually sexual 
3 Varicella ~lphaherpesvirinae ~ucoepithelia !Neurons Contact or 
Zoster Virus respiratory 
(VZV) route 
4 fE1? s tein Barr gammaherpesvirinae epithelial iB Saliva 
r-rirus (EBV) cells, B lymphocytes 
lymphocytes 
5 Fytomegalovirus ~etaherpesvirinae JEPithelia, jMonocytes. lContact, blood 
Im°ncyctes, B Lymphocytes transfusions, 
lymp:,.ocytes land possibl :, transplantation I 
others congenital 
6 ~uman Herpes ~etaherpesvirinae T lymphocytes rr ~ontact, ~irus 6 and others lymphocytes, respiratory 
!monocytes route 
7 ~uman Herpes ~etaherpesvirinae rr l ymphocytes rr f'nknown 
r-rirus 7 and others lymphocytes, 
monocytes 
fK,aposi's gammaherpesvirinae Endothelial B iExchange of body 
Sarcoma cells, B lymphocyt es fluids 
8 ~ssociated 
~erpesVirus 
lymphocytes 
(KSHV) 
5 
Genetic Organization of the Gammaherpesviruses 
Complete genome sequences exist for 12 gammaherpesviruses [McGeoch et ai, 2005]. 
Gammaherpesviruses have historically presented a challenge in phylogenetic organization due to 
the inconclusive position of MHV 4 (MHV -68) which is associated with a high level of sequence 
change, and difficulty in resolving branching order within the Rhadinovirus genus. The position 
of MHV -68 seems to vary with the analytical method used, and the accelerated rate of change in 
the genome may represent some differences in biology to the other gammas. At the same time, 
the high number of substitutions in the MHV-68 genome imparts some similarity to both 
lymphocryptoviruses and rhadinoviruses [McGeoch et ai, 2005]. 
The gammaherpesviruses have maintained the overall genomic layout of the herpesviruses, 
containing the conserved order of 42 genes belonging to the ancestral core set of mammalian 
herpesviruses, within a region of unique sequence flanked by terminal repeat elements. These 
genes vary however, as a result of extensive nucleotide substitution and local base pair additions 
and deletions. Furthermore, members of the subfamily share a core set of eight gamma specific 
genes, concentrated at a few genomic loci, which confer their special characteristics, notably 
lyinphotropism and malignant transformation [Nicholas et ai, 1998]. However, as a result of 
variations in genome size and base composition, no two viruses have identical complements of 
these conserved genes [McGeoch et aI, 2001]. The genomes of four representative 
gammaherpesviruses are shown in Figure 1. 
6 
Figure 1 
Genetic Organization of gammaherpesvirus genomes 
Schematic representation of the organization of the gammaherpesvirus genomes based on 
sequence analysis. Adapted from [Nash et ai, 2001] ; Fowler, personal communication. KSHV 
and MHV-68 are rhadinoviruses infecting B cells, while HVS is a rhadinovirus latently infecting 
T cells. On the basis of its genetic organization, and its mechanisms of latency establishment and 
maintenance, MHV -68 is more similar to KSHV than to EBV,a lymphocriptovirus. The genome 
ofEBV is shown in reverse orientation (Left to Right) to facilitate comparison to the 
rhadinovirus genomes. Conserved genes involved in DNA replication and virion architecture are 
represented by open boxes. The genes specific to the gammaherpesviruses are labelled above and 
below the respective genome. Latency associated proteins are shown as orange boxes. 
Abbreviations: CCPH: complement control protein homolog; CKBP: chemokine binding protein; 
CRP: complement regulatory protein; DHFR: dihydrofolate reductase; EBNA-1 :Epstein Barr 
_.,-
Virus nuclear antigen 1; LAMP: latency associated membrane protein; LMP: latent membrane 
protein; STP :saimiri transforming protein; TK: thymidine kinase; TS: thymidylate synthase; 
vFLIP: viral FLICE inhibitor protein; vGPCR: viral G-protein coupled receptor; vILl7:viral IL-
17; vIL6: viral IL-6; vILlO: viral IL-IO;vIRF: viral IFN regulatory protein; vMIP: viral 
macrophage inflammatory factor; vOx2: viral Ox2 
7 
KSHV 
0\ .!: a: 
~ ~~ ~"R~ 
::::! U C!l Vlii't l!l 
»> 1-»> 
HVS 
.~ .!: a:: 
o a. "U<i NU c.. 
Q. :J iiz Xc.. ~ 
10 U. I c:( Ol!l c:( a:: 
::l »--1» --II-
a: 
>-
I t t D~B~~@ t=1 1 ==17-50 =~==52-69=I U~~~a l 
~ 
MHV-68 :;: "-
z CIl "-~ 0 u 
o 10 20 30 40 50 60 70 80 90 100 110 120 130 140 kb 
I I I I I I I I I I I I 
I I I I 
o 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 kb 
EBV 
~ latency-associated ~ modulators of ce ll ~ membrane ~ modulators of ~ cytokines and t nucleotide ,. t viral proteins t regulators of Proteins cycling and signal glycoprotein immune response chemokines metabolism Involved In . apoptosis transduction transformation 
8 
EBV genetic organization 
EBV is the only human Iymphocryptovirus. The genes responsible for host cell transfonnation 
and maintaining the viral genome in dividing cells have been well studied in EBV and its primate 
virus relatives [McGeoch et ai, 2001]. The left tenninal region of the EBV-l genome houses the 
lymphocryptovirus specific LMP-l gene. The right tenninal region houses the latent membrane 
protein LMP-2, LP and EBNA -2 genes. The EBNA-3 group of distantly related genes is placed 
tandemly at an internal locus of the genome, as is the EBNA-l gene. A giant transcript which 
extends across most of the genome produced in several versions undergoes differential and 
complex splicing to express the EBNA and LP genes in latently infected and transfonned cells 
[Zhang et ai, 1994]. This replication system is unique to the lymphocryptoviruses. 
EBV pathogenesis 
EBV ·is the causative agent of infectious mononucleosis, and is implicated in the pathogenesis of 
Burkitt's lymphoma, some instances of Hodgkin's disease, immuno-blastic lymphoma and B-
lymphoproliferative disorder in immuno-suppressed individuals. Epithelial malignancies caused 
by EBV include nasopharyngeal carcinoma and gastric lymphoma [Purtilo et ai, 1992] ; [Straus 
et ai, 1993]; [Farrell 2002]. Rarely, T cells are infected, as is the case in EBV derived T-cell 
lymphomas. 
9 
Several viral genes collaborate to immortalize B cells. Viral LMP-l up-regulates bcl-2, 
preventing apoptosis of B cells. LMP-l also activates growth promoting pathways, usually 
stimulated by T cell delived signals [Hu et ai, 1993] ; [Kumar et ai, 2005]. In vitro, expression of 
LMP-l renders rodent cell lines immortal, and occaisionally, tumorigenic [Moorthy et ai, 1993]. 
EBNA-2 activates LMP-l transcription, and trans-activates host genes such as cyclin D and the 
src tyrosine kinase proto-oncogenes. 
EBV is tropic towards epithelial cells ofthe oropharynx, and B lymphocytes. Viral uptake into B 
cells is facilitated by CD21 present on B cells, with circularization of the viral genome to form 
an episome. EBV enters latency upon infection ofB cells, due to a failure ofBZLF 1 to activate. 
Reactivation requires activation of BZLF I which occurs on B cell differentiation to a plasma 
cell. 
KSHV genetic organization 
KSHV was discovered in 1994 [Chang et ai, 1994]. Its molecular evolutionary biology has been 
challenging to study, due to the diversity of the leftmost gene in its genome, Kl from HHV-8 
isolated from different individuals. The Kl sequence encodes a type I glycoprotein which has the 
-. 
ability to transform cells with the diversity proposed to be either an immune evasion mechanism, 
or a necessity for interaction with a host component that is quite variable in human populations 
[Lee et ai, 1998] ; [McGeoch et ai, 2000] and consistent with human genetic diversification and 
global spread. 
10 
KSHV pathogenesis 
KSHV is implicated in the etiology of the angiogenic tumor Kaposi's Sarcoma (KS), the HIV 
associated Iymphoproliferative diseases Multicentric Castleman's Disease and Primary Effusion 
Lymphoma [Soulier et ai, 1995] ; [Cesarman et ai, 1996]. 
Horizontal transmission by saliva is thought to be the most common route of transmission. KS is 
described as a neoplasm of primitive mesenchymal or endothelial cells whose course greatly 
depends on the immune state of the afflicted individual. Both HIV products and HHV-8' are 
thought to playa role in pathogenesis, with locally produced cytokines acting in a paracrine or 
autocrine way to stimulate unchecked growth of tumor cells [Kumar et ai, 2005]. 
Endothelial cells are believed to be the precursors of spindle cells, are the site of latent infection 
in vivo, and are permissive to KSHV infection in vitro. A subset of infected cells manages the 
larger microenvironment in KSHV infection. This conclusion is drawn from initial experiments 
in vitro, where less than 10% of cells were infected after serial passage, yet, these KSHV 
cu1tures had extended life spans, acquired telomerase activity and made colonies on agar -
suggesting that some transformation event had occurred [Wang et ai, 2005]. 
11 
Five KSHV proteins are produced during latency in infected lymphoma cells. These include 
LANA-I, v-cyclin-D, FLICE inhibitory protein (v-FLIP), V-IL-6 and LANA-2. A single 
tricistronic mRNA is alternatively spliced into LANA-I, v-cyclin and v-LFLIP gene products, 
the expression of which comes from an internal ribosome entry site (IRES) [Bieleski et ai, 2001]. 
LANA-l has transcriptional effects on both cellular and viral genes. It is required for episomal 
maintenance, can transform cells, inactivates Rb and p53 thus immortalizing cells, and causes 
lymphoid tumors in transgenic mice [Ballestas et ai, 1999] ; [Friborg et ai, 1999]; [Fakhari et ai, 
2006]; [Radkov et aI, 2000]. LANA represses the RTA promoter, thus inhibiting the lytic cycle 
and maintaining latency. 
V-cyclin D acts as a cell cycle regulator, and in the absence of p53, destabilizes the cellular 
genome, allowing for the expansion of tumorigenic clones [Verschuren et ai, 2004]. v-Bcl2 and 
v-FLIP activate anti-apoptotic pathways and v-IL-6 is a viral cytokine stimulating clonal 
expansion [Cesarman et ai, 1996] ; [Moore et ai, 1996]. Thus, the human gamma herpes viruses 
EBVand KSHV are able to drive the proliferation of latently infected cells, causing lymphoid 
and epithelial tumors, which occur with increased frequency following immuno-suppression. 
Therefore, control of gamma herpes virus infections represents a major clinical goal. 
" 
Unfortunately, the species specificity of the human gamma herpes viruses EBV and KSHV has 
hindered study of these human herpesviruses in animal models, and study of simian homologues 
in primates has proved costly. The genetic and immunologic profile of the laboratory mouse, 
however, has been well characterized. 
12 
MHV68 efficiently infects the laboratory mouse and presents a representative gamma herpes 
virus whose pathogenesis can readily be studied in this small animal model [Adler et ai, 2001] ; 
[Nash et ai, 2001] . 
MHV -68 Genetic Organization 
The complete genome ofMHV-68 clone g2.4 is available, with 81 genes identified [Virgin et ai, 
1997] ; [Nash et ai, 2001] . In addition to the cellular homologues and genes conserved in the 
genus, a unique set of genes Ml to M4 are present in the genome, and a set of eight virally 
encoded tRNAs expressed during latency, of undetermined function [Bowden et ai, 1997] ; 
[Macrae et ai, 2003] ; [Simas et ai, 1998]. tRNAs contain the polIII promoter driving expression 
of miRNAs, which regulate gene expression post transcriptionally [Pfeffer et ai, 2005]. The 
MHV-68 genome encodes the well conserved genetic sequence ofORF50, which is homologous 
to ORF50 in KSHV, HVS, RRV and BRLF1 in EBV [Damania et ai, 2004]. 
ORF50 has been identified as the major immediate early gene encoding Rta, the viral 
transcriptional activator. Rta has been shown to be necessary and sufficient to induce the full 
lytic cycle of gene expression, similar to the role ofRta in KSHV and EBV. This protein plays a 
central role in viral reactivation from latency [Liu et ai, 2000] ; [Wu et ai, 2001]. ORF50 is the 
sole trans-activator and thus the regulator of the switch between lytic and latent cycles in all 
these viruses except EBV which also encodes BZLF1, with its gene product Zta implicated in 
this process. 
13 
MHV-68 pathogenesis 
MHV-68 was originally isolated from bank voles in Slovakia [Blaskovic et ai, 1980]. Chandra et 
al showed that MHV-68 was able to latently infect a range of B cell lines, including NSO mouse 
myeloma cells, with reactivation and lytic gene expression occurring in approximately 5% of 
cells [Sunil-Chandra et ai, 1992]. 
The natural route of transmission ofMHV-68 is unknown. However, following intranasal 
infection oflaboratory mice, viral replication occurs in lung epithelial cells. Long-term latency is 
established primarily in B lymphocytes, and macrophages are the major reservoirs in peritoneal 
cells, although virus also persists in lung epithelial cells and dendritic cells [Weck et ai, 1999] ; 
[Simas et ai, 2004]. 
CD4+ T cells mediate splenic B and T cell expansion, resulting in splenomegaly within two 
weeks. By the third week post infection, an infectious mononucleosis like syndrome occurs, and 
with chronic infection, approximately 10% of mice develop B celllymphoproliferative disease 
[Nash et ai, 2001]. In tissue culture, murine B cells exhibit CPE within three to four days post 
infection, and die within two weeks as no transformation occurs [Dutia et ai, 1999]. Addition of 
cytokines and other growth factors to media may prolong the life of cultures to two months, but 
no immortalized cell lines have been established. Infected B cells in culture do however show 
increased survival over mock infected cells, with MHC I expression increased, and virus 
encoded tRNAs identified in infected B cells, but no lytic transcripts evidenced. 
14 
BALB/c beta2 micro globulin deficient mice (BALB beta2m-/-) have proved useful for studying 
MHV-68 pathogenesis. MHV-68 infection results in B cell lymphoma (B220+/CD3-) and 
atypical lymphoid hyperplasia resembling lesions in EBV associated post-transplant 
lymphoproliferative disease [Tarakanova et at, 2005]. 
While our knowledge of gannna herpes virus pathology has vastly increased, there still remain 
many outstanding questions. The early events of gammaherpesvirus infection remain unclear, as 
does the role of viral genes in initial infection, the mechanisms involved in the transition to 
latency, the sites oflatent infection, the role of the immune response in limiting virus infection 
and contribution to the immuno-pathology associated with the gannnaherpesviruses. 
The ability of the herpes viruses to establish and reactivate from latency is central to the survival 
strategy of these viruses. The aim of this reseal"ch is thus to establish an in vitro model of MHV-
68 latency which can be used to characterize the latency gene products encoded by this virus. 
The MHV68 genome has been fully sequenced and cloned as an infectious Bacterial Artificial 
Chromosome (BAC) [Adler et at, 2000]. Using targeted mutagenesis of the MHV-68 BAC, 
MHV -68 mutants can be constructed and reconstituted in vitro by transfection into eukaryotic 
cells, for analysis. Given the central role of ORF50 as viral trans-activator between latent and 
lytic cycles, the generation of ORF50 mutants provides an ideal system for studying the 
mechanisms involved in latency establishment and reactivation from latency [Virgin et at, 1997]. 
15 
Models for MHV-68 Latency 
Other model systems are in use for the study oflatency however they each have significant 
limitations. The Sllcellline is derived from a B -cell lymphoma from BALB/c immuno-
deficient mice latently infected with MHV-68 which subsequently developed 
lymphoproliferative disease [Usherwood et at, 1996]. The S 11 cell line has provided an 
amenable system for the study of latency as this is a clonal population in which every cell 
co'ntains tbe MHV -68 genome, 
For example, the latency associated gene product M2 which has anti-apoptotic properties was 
discovered by analyses on this cell line [Macrae et at, 2003]. Furthermore, virus can be 
reactivated from latency by supplementation of the ORF50 gene product in trans [Wu et at, 
2000]. There are however, limits to the utility of this system in the study oflatency. While 
reactivation frequency is low, S 11 cultures can undergo spontaneous reactivation, thus producing 
lytic gene products, with cultures becoming increasingly lytic with each passage [Husain et at, 
1999]. Furthermore, given the derivation oftbis cell line from lymphoma cells latently infected 
in'vivo, the possibility exists that more than one viral genome may be integrated in tbese cells 
[U sherwood et at, 1996]. 
The NSO cell line, also ofBALB/c origin is a myeloma derived line which is attractive for the 
study oflatency given that B lymphocytes are the natural site oflatent infection in vivo [Sunil-
Chandra et at, 1992]. NSO cells infected with MHV-68 yield predominantly circular genomes, 
indicating latent infection. 
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Some infectious virus remains detectable in latently infected cultures however, with a small 
proportion oflinear genomes present indicating lytic infection. The linear genomes are 
successfully abolished with application of acyclovir [Sunil-Chandra et ai, 1992]. The 
requirement for acyclovir treatment to maintain latency makes this model system less than 
desirable for in vitro studies oflatency. 
Both of these model latency systems are thus based on producer cell lines in which there is 
always a background level of lytic replication taking place, limiting their utility in the 
characterization of the latent transcriptional profile, and the identification of novel latent 
transcripts. 
Rationale/or the ORF50 latency system 
In the rhadinoviruses, a single key transcriptional activator, Rta, encoded by ORF50, initiates the 
lytic cascade [Hardwick et ai, 1988]. The transcription of Rta in the presence of cyclohexamide, 
a protein synthesis inhibitor, identified it as an immediate early gene product [Liu et aI, 2000]. 
Kinetic studies performed in MHV-68 infected BHK-21 revealed that the ORF50 transcript is 
the major transcriptional product produced by 2 h.p.i. Reactivation studies in latently infected 
S 11 cells indicate that transfected Rta cloned into an expression plasmid can disrupt latency, 
resulting in initiation and propagation of the lytic cycle [Wu et ai, 2000] . 
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The trans-activating function ofRta has been localized to the C terminus, while the highly. 
conserved N-terminus mediates DNA binding and dimerization [Lukac et aI, 1999]. Rta mutants 
with deletions in the C-terminus trans-activating domains lose the ability to initiate lytic gene 
expression. Furthermore, cell lines stably expressing these null mutants are resistant to lytic 
infection with WT MHV -68 as the competing non functional Rta product inhibits functional Rta 
auto-activation [Wu et aI, 2001]. 
The ORF50 gene encodes a spliced and unspliced product, with the transcription initiation site 
for both products located downstream of ORF49. The ORFs 49 and 50 are encoded on opposite 
strands and face each other, with ORF49 interposed between the two exons ofORF50. During 
splicing to produce the major Rta transcript the region antisense to ORF49 is removed with 
extension of the ORF50 gene, a conserved feature of gammaherpesvirus ORF50 [Whitehouse et 
aI, 1997] ; [Liu et aI, 2000] . 
The function of the un-spliced transcript in MHV-68 remains to be elucidated, although multiple 
bicistronic alternatively spliced ORF50 transcripts have been identified in KSHV and RRV. 
Prior studies in HVS indicate that the spliced transcript encodes the lytic gene trans-activating 
abilities ofRta [Whitehouse et aI, 1998; De Wire et aI, 2002]. 
A Rta null mutant has been previously described, in which a stop codon was introduced into the 
spliced ORF50 transcript coding region accompanied by a 2bp deletion resulting in a frame shift 
[Pavlova et aI, 2003]. Contaminating WT virus was present in 1 in 3 xlO 4 to 1 in 10 5pfulml. 
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In vitro studies revealed that the ORFSOstop mutant was replication defective, unable to replicate 
viral ORFSO DNA as assessed by RT-PCR, however WT replication could be initiated when 
ORFSO was supplied in trans in a complementing cell line. Immunoblot assays indicated that the 
ORFSOstop mutant failed to produce viral proteins by 24hpi, compared to WT virus, which 
produced several lytic proteins. 
Murine in vivo studies using this MHV-68 t..SOstop mutant revealed that the replication defective 
mutant virus persisted in B cells at the site of infection (lung) but failed to establish latency in the 
spleen indicating that virus replication is necessary for the overall establishment of splenic 
latency [Moser et ai, 200S]. 
In addition to ORFSO's transcriptional regulation of the viral genome, Rta exerts transcriptional 
effects on the cellular genome as well. An MHV68 mutant over-expressing ORFSO has been 
shown to dysregulate transcription of cellular genes involved in cell adhesion (VCAM-l), cell 
growth (FGFIO) and inflamrnation(Tnfip6), and consistent with WT MHV-68, up-regulate 
nuclear hormone receptor Nur77 and immune inhibitory hilla, for example. These cumulative 
effects are potentially crucial for lytic replication [Hair et ai, 2007]. 
Studies in S 11 cells showed that time of expression is closely linked to function in the 
transcription program ofMHV-68 [Usherwood et ai, 1996]. The activation of the ORFSO 
promoter results in the trans-activation of other IE viral transcriptional regulators, such as ORFS7, 
which like ORFSO peaks within 8 hours post infection, and are identified by transcription of their 
mRNAs in the presence of protein synthesis inhibitors [Martinez-Guzman et ai, 2003]. 
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Furthermore, Rta also regulates its own promoter through the Oct-l transcription factor, and 
assists in Sp-l mediated and general transcription [Zhang et ai, 1998]. This auto-activation 
results in the irreversible progression of the lytic cascade. IE gene products activate delayed 
early genes (DE) encoding proteins effecting viral DNA replication, such as ORF9 encoding 
viral DNA polymerase, expressed 8 to 12 hours post infection. 
Early (E) gene products include among others M7 glycoprotein 150 and ORF 49, peaking 
between 12 and 24 hours post infection, with the eventual activation oflate (L) genes encoding 
viral structural proteins whose production peaks at 12 to 24hpi [Martinez-Guzman et ai, 2003] . 
Latency associated gene products such as M2 also peak late in infection, after 32 hours. Rta can 
negatively regulate transcription of the Latency Associated Nuclear Antigen encoded by ORF73 
[Hair et ai, 2007]. Interestingly, ORF73 encoding the Latency Associated Nuclear Antigen, is an 
immediate early gene, peaking within 8 hours post infection, yet it is the key regulator ofthe 
latent state, analogous to ORF50 in lytic infection [Ballestas et ai, 1999]. 
The time course of its expression indicates that while lytic infection is the default pathway upon 
plimary infection in vitro, the viral survival strategy of latency is initiated early on in the process 
of infection. LANA acts by repressing the transcription ofORF50 [Lan et ai, 2004]. Reactivation 
-, 
occurs under chemical induction by agents initiating activation of cellular pathways resulting in 
de-repression of the ORF50 promoter. For example treatment with trichostatin A (TSA) results 
in inhibition of histone deacetylase, with subsequent de-repression [DeWire et ai, 2005] . 
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Ectopic expression of ORF50 in latently infected cultures, results in reactivation, and the 
conservation of its function is evidenced by the ability ofMHV-68 and RRV ORF50 to 
reactivate KSHV from latency [Damania et ai, 2004]. In summary, ORF50 is necessary and 
sufficient for reactivation from latency, thus ORF50 null mutants present an ideal system in 
which latency can be studied. 
These mutants can be generated using the BAC plasmid cloning and mutagenesis protocol, with 
subsequent reconstitution of mutant virus in cell culture [Adler et ai, 2000] ; [Adler et ai, 2001]. 
These IE deficient mutants can then be utilised to co-ordinately latently infect large numbers of 
cells in culture. 
Prior to my arrival, the Efstathiou lab had created an immediate early gene mutant carrying the 
reporter gene luciferase instead of ORF50, under the ORF50 promoter. Given that the ORF50 
promoter is suppressed during latent infection, and activated during lytic infection, it appeared 
that the presence of this reporter gene could be used as an indication oflytic infection. It had so 
far been demonstrated that latent -infection could be established in BHK-21 cells, and 
furthermore, the virus could be reactivated from latency. 
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AIM 
My project involves the next step, which is determining whether the !':.50 latency system 
represents an inducible and reliable latency system, devoid of the lytic contamination that has 
confounded previous latency systems. This involves establishing latency in the model 3T3 cell 
line, and testing this process in a macrophage and B cell line, where latency occurs in vivo. 
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CONSTRUCTION AND CHARACTERIZATION OF THE 1\50 MUTANT 
Materials and Methods 
Reagents 
General reagents were provided by Sigma Chemical Company and Aventis. Plastics used in 
tissue culture were supplied by Falcon and TPP Ltd. PBS was prepared by the technical staff at 
the Department of Pathology. All other reagents used and their suppliers are listed in Appendix 1. 
Cell Lines and Tissue Culture 
1'-.50 mutants are replication defective, thus a complementing cell line supplying ORF50, the 
3T3/0RF50-fibroblast line, Clone 11, was developed to grow viral stocks (Figure 2). 
23 
NIH 3T3 , Clone II, NSO and RAW macrophage cells were cultured in DMEM supplemented 
with 10% FCS, 4 mM L-glutamine, 100U penicillin G mrl, 100mg streptomycinmrl and 1% 
non essential amino acids. Clone II cells were supplemented with 200uglml hygromycin, 
200uglml G418, 5uglml puromycin to maintain repression of ORF50 production. Baby Hamster 
Kidney-21 cells (BHK-21) were grown in GMEM containing 10% FCS, 10% tryptose phosphate 
broth, 2m.M L-glutamine, 100 U penicillin mr], and 100ug streptomycin mrl. 
Cells were grown by incubation in 50ml flasks, at 37°C in a 5% C02 humidified environment. 
Cells were harvested on reaching confluence by removing media, rinsing with PBS, 
trypsinization with incubation to release single cells from the monolayer matrix, and pelleting by 
centrifugation at 1500 rpm in a IEC 6000B rotor. Cells were then re-suspended in fresh media, 
plated in a new flask, and in this way maintained over several generations of cell division. 
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Figure 2 
Schematic Diagram showing the design of the inducible Clone II cell line supplying Rta in trans 
to !'.50 mutants (Adapted from the Clontech Tet On System Advanced Manual). 
The Clontech tetracycline inducible system was adapted to generate an ORF50 complementing 
mouse embryonic fibroblast cell line, Clone II (Coleman, Bennett, personal communication). 
The tetracycline responsive element (TRE) promoter encoding a HCMV promoter and several 
tetO sequences hybrided onto the tetracycline trans-activator tTA in the presence of a silencer 
element (tTS) were fused to generate a 3T3 fibroblast cell line stably expressing TRE-rtTA and 
CMV-tTS. Transduced cells were selected using the antibiotic resistance markers puromycin and 
hygromycin respectively. The genomic fragment containing ORF50 (66754 to 69377) with an 
ATG at 66760 bp and an ATG at 67661 bp on splicing was amplified by PCR, including EcoRI 
and ClaI restriction sites in the 5' and 3' primers. The ORF50 PCR product was cloned into the 
5' end on Sail site on pREVTRE and the pREVTREORF50 retroviral expression plasmid was 
then transfected into NIH-3T3 cells already containing the TRE-rTA and CMV-tTS cassettes. 
ORF50 was thus inducibly produced in trans in the presence of doxycycline, and suppressed in 
its absence. 
Key 
3T3-Clone 11: inducible 3T3 fibroblast cell line supplying ORF50 
pCMV: cytomegalovirus promoter 
DOX: doxycycline 
MHV -68/TRE50: cloned MHV68 ORF50 gene under TRE promoter control 
rtTA: reverse tetracycline trans activator 
pTRE: tetracycline responsive element promoter 
tTs: tetracycline silencing element 
50: ORF50 gene product 
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Table 2 
Description of cell type,infectivity and source for cell lines used. 
Cell Line Cell type Description Source 
BHK-21 Fibroblast Permissive (American 
mouse Type Culture 
embryonic Collection, 
kidney cells CCL-IO 
NIH 3T3- Fibroblast Permissive American 
mouse Type Culture 
embryonic Collection, 
fibroblast line CRL-I658) 
Clone 11 (NIH Fibroblast As above, American 
3T3/0RF50-) supplementing Type Culture 
ORF50 in trans Collection, 
on induction with CRL-1658) 
doxycycline Coleman, H.M 
p,ersonal 
communication 
RAW 264.7 Macrophage Non permissive, Rosa, personal 
enhanced communication 
infectivity with 
antigp150 
antibody, latent 
site in vivo 
NSO BALB/c Non permissive, American 
myeloma primary site of Type Culture 
derived latency in vivo Collection 
lymphoblast CRL-11177 
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Viruses 
Several t.50 recombinant viruses were generated by the laboratory ( Coleman, Freitas, personal 
communication), using the BAC mutagenesis protocol [Messerle et ai, 1997] ; [Borst et ai, 1999]. 
The ORF50 ATG translation initiation codon is located at 67907 bp, and the gene comprises of2 
exons interposed by ORF49. The genomic fragment with genomic co-ordinates 66642-69462 bp 
contain the entire ORF 49 and ORF 50 [Liu et ai, 2000]. Splicing removes the intronic ORF49, 
with extension of the ORF to encode an additional 94 amino acids likely encoding an ATG site 
as occurs in KSHV [Sun et ai, 1998]. Putatively, the ORF50 promoter is located between 66442-
66552 bp, with a TATA box from 66439-66444bp. Briefly, the genomic fragment from 63844-
70433bp was cloned into a pUC19 shuttle vector in the HincII site, and an oligo adaptor 
containing ClaI (69177) restriction site added into the BsmI site (67792). ClaI digestion enabled 
excision of a 1385bp fragment (67792-69177) from exon 2 leaving a 5' 131bp overhang (67661-
67792) with an additional 41bp contributed by exon 1 on splicing. A 196 bp (69177-69373) 
overhang remained at the 3' end of exon 2. Luciferase derived from p21uc then replaced the 
deleted ORF50 gene sequences with a 978bp (658-1636bp) and a 1922(l658-3580bp) reporter 
gene fragment, with the sequences cloned into the p.UC19/HincIIB plasmid digested with ClaI. 
An alternative reporter system was constructed by attaching the enhanced GFP coding sequence 
to ORF39 (56950-55799) encoding the late glycoprotein gM at the C terminus, onto this t.50 
knockout background (Smith, personal communication; [May et ai, 2005] ) . The mutated 
MHV68 gene fragment is shown in Figure 3, and a schematic representation of the mutant 
viruses is shown in figure 4. 
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Figure 3: Nucleotide Sequence of the MHV-68 ORF50 gene adapted from MHV-68 nucleotide sequence, GenBank 
Accession Number AFI05037. The sequence is shown 5' to 3 'from 67660 to 69373 base pairs, which spans the 
ORF50 Exon 2. The ATG site, at 66760bp, precedes ORF49, and is capitalized. The deletion from 67792-69177bp 
of Exon 2 is highlighted in blue. The 5' and 3' overhangs of Ex on 2 remaining after deletion are highlighted in red. 
66721 aaaaataeaa eteetgeaet aegagggaat ttetgeageg ATGgeetetg aeteggatte 
66781 eeetteagee gataaggtag gtaaaeattt tatataaatt tgtaaaeeae geagaeagat 
66841 eagtatttea teaaaaaeta aagtgttgtt aetagtetga agtetgtgga geagatggtt 
66901 taagttagae aattttgeee aeaeaaeaga tgtgetatag eagageaggt ttgtgteaga 
66961 tteeaeaate gettetaaet ettttaeatg atttttaaaa agggeattaa atgeeaeaag 
67021 getgteeage agaaaetgae tttggaeaea aaeaetgaae agtttaaaga egettaeeea 
67081 ataeaeaagg aeattgagte eagtagataa ateaaagtet geagetgttt etaaetetag 
67141 tgaataettt aagaatgttt taaagttgta eatataagaa aagtgtttat tgteeaaeat 
67201 agaagatatt ttteteaagg etteetegte taeagaggte aggaaaeatg eaeaeeatte 
67261 atgtaeagge tgatetttgt eatatgggat agaeaaaate tetggaettt gaeageeeag 
67321 taaattgaea gtgeetatgg eeaagtettg taaeaagttt gaateatttg eeteaaggga 
67381 tagetteatg tagtegagta tgegetgaaa tttggaggta gtggaeaaee teteeaatag 
67441 tgttaggtgt etgataatta gtteeeteaa gtggggeaae aaaaatgget etgtateeaa 
67501 gttgtggege agtgtetgae aaattttaea eageaeetga agettaeaea aaeaggeaet 
67561 taetetatta tgtteeetag tatetatgae aeaaaaggtg tggaeeaege ttteeagaga 
67621 aggataataa aatteateee eeatgtttte tgttettata ggaetggeae ggategaage 
67681 aggtetaett gageeagttg attggagtet etgetgaaae aaaagaggaa ttteageaae 
67741 tggtagatet atttatatge tteetaeage aeeetgaaga tggtttgaat getetgeagt 
67801 atgteaagaa tttggaaett getettegge gtetgeagte agaeagtete aaaeatggge 
67861 etttgtetgg gttaatattt gaeetgaaet tetaeaatgt etgggtaatg tteagaaaee 
67921 agaaggtgag gtttaatgee aaagteeata aeaggeatee atgtgggtae atateteaee 
67981 aeetgateaa atatgeeatt gaaagagttg tetataeeae agaeaggetg tttetgaetg 
68041 eeeeatgtte gggggtaeag etaeeteaae etetggeetg eagtetgtte gaaataetea 
68101 aggatgttag aggaaaatge aeaaeggeet ggaggegett aggggeagge egeagaeatt 
68161 taatgaeatt tgggegeaat gtgttggatg aatttaatte tgagaagaag teaeetggtg 
68221 geatateeag agaagttgag geatttataa agatatgett teeaeaaatg gaettaaata 
68281 aaattttaat teeaatttat eageaegeea teaaeateee aeeagaetgt gtaeeeaget 
68341 gtaetattgg agatggaaae agaaaaegag eeeeeeaegg ttegetatae agtaaagaea 
68401 tateeteaea aaagttetge ateeeagaee eeetgtttge tteteeeaea gaaeeagggt 
68461 tgggggagtt geataggggt aatatggeae atttgetgea gaaeeeagaa gaaateatta 
68521 aeetggaeee tetaeaeaat aeeaetgaae eetgtttgta teaaatgttt teagaggegg 
68581 tgaeaaaeee etetaaaaaa agatggettt ettettteaa eatggtettt teaggaetgt 
68641 eteegagage teggeeagag aeeaettatg aaeeattggg geeattttea eeeattagee 
68701 etggeeette tteegeeaea gaagagttee agtttgaatt tageeettet eeteaaaeet 
68761 eeeeagaaae aagegageag agetaeatae etaeteeeaa eteagetatg ggeggateet 
68821 ttgagtaeae aggegeegtt eaaeeaeaae taatteeaga taateaeaee tgtteegeaa 
68881 agagattaag ggagagegat gaggaggtaa attattette agaeggtagt eeaaaeaaga 
68941 aaeeeaeage tegeaettet gggeaegaae aggettatgg ttttetggee gagttgetet 
69001 etageeaeag ggataegeet gteeageata ttgtgeaate tggeteaaeg eeegeeeege 
69061 eaattgttga geeteaggga eaagattttg ttggaaaaea ggatgagaea tgtteeaaeg 
69121 tgtteeeaga aeaaattaet eaggaagegt gteeeggate atetgaggae gegtteateg 
69181 atgatgetat aaaggaaata tttgeatege tggaetetat ggeaaaeeag gaeaetgetg 
69241 acagtgacac atgttccata cttgaccccc aatcacccac tcccccaccc tccgttcccc 
69301 eaataaetae aetetegttg tatgaeattt atgeeageat aettagteea etegaeeeaa 
69361 aeageetgga gte 
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Virus Stocks 
All viral stocks used were prepared by the author. Wild type (WT) viruses were grown on non 
complementing BHK-21 cells, while b.50 viruses were grown on Clone 11 cells in the presence 
of doxycycline at Img/m1. Cells were seeded at I X107, infected with virus at O.Olpfulml and 
followed for plaque formation. Mock-infected (medium only) cells were included as negative 
controls. By 4-5 days, 100% CPE was achieved. Cells were harvested by scraping into media, 
collecting the supernatant into SOml flasks, and pelleting by high speed centrifugation for 7 
minutes. Cell pellets and virus containing supernatant were separated and subjected to the 
following treatment. Pelleted cells were sonicated for 3x20 seconds on ice, and the resulting 
slurry collected as the cell associated (CA) viral stock. Supernatant was collected into Oakridge 
tubes for ultracentrifugation using a Beckman Type JA 25.5 rotor at 18,000 rpm for 2 II hours. 
Supematant was poured off and the resulting viral pellets re-suspended in I 0-12ml of 10% 
DMEM. The resultant slurry was sonicated for 3x20 seconds on ice and aliquoted into l.5ml 
eppendorftubes as the medium purified (MP) viral stock, and stored at -70°C. A list of wild type 
and b.50 viruses used is provided in Table 3. Unless otherwise specified, WT virus used in all 
assays was the PHA3.3 WT virus which is wild type MHV-68 contained within the BAC cassette. 
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Table 3 
The 6.50 and WT MHV -68 viruses used 
Virus Mutation 'Phenotype 
True WT MHV-68 Strain g2.4 WT 
PHA3.3 Contains BAC sequence WT 
WT - revertant REVERTANT from "SOluc WT 
"SOluc ORF50 deletion replaced with replication deficient, expressing 
luciferase reporter gene luciferase on Rta 
complementation 
"50IucgMGFP ORF50 deletion with eGFP Replication deficient virus, 
attached to C-terminus of gM expressing gM-EGFP fusion 
protein on Rta 
complementation 
' Both BAC positive and BAC excised viruses were available, with BAC cassette derived GFP expressed by BAC+ 
mutants on infection. 
31 
Titration of Stocks 
Virus titres were determined by monolayer assay. Aliquots of3001l1 of virus stock and 2.7 ml of 
media were serially diluted and plated in duplicate over six well plates containing 3xl05 clone 11 
cells + 1 mg/ml doxycycline for mutant virus assays or 2 xl05 BHK-21 cells for wild type 
viruses, seeded the day before to confluence. Following a one hour incubation period, 3mls of 
1 % CMC was added to limit convective viral spread. Cultures were followed for CPE (3-4 days) 
and harvested by removing CMC media, and fixing with 10% formaldehyde in PBS for 30 
minutes. Plates were stained overnight with toluidine blue, rinsed, dried and individual plaques 
counted at each dilution, in duplicate. The number of infectious virus particles in the original 
virus suspension was then calculated. 
Screening of Stocks for Wild Type Contamination 
Stocks were screened for WT virus by seeding large T150 flasks with 10 7 cells overnight to 70% 
confluence, and infecting with 10 5, or 104 pfu of "'50 mutant virus. T75 flasks were infected 
with 10 3 or 10 2 pfu of "'50 mutant virus. A Tl50 flask ofBHK-21 cells was infected with WT 
virus at 10 2 pfu as a positive control. 10 ml of 3% FCS was added to infected cultures which 
were then incubated at 37°C with shaking for 1 hour. 32ml and 20ml of 1 % CMC was added to 
Tl50 and T75 cultures respectively. Infected cultures were followed over the course of7 days 
for green fluorescence and for CPE with plaque formation. 
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At 7 d.p.i, 5ml of supernatant from infected cultures were placed onto fresh BHK-21 cells seeded 
the day before to 70% confluence. These fresh cultures were incubated with shaking for lh at 37 
°C, and 20ml of 3 % FCS media added. Fresh cultures were followed over the course of 5 days 
for CPE and green fluorescence, which would indicate infectivity of initial cultures, and 
verifYing the presence of replication competen WT virus. 
Growth Curves 
Wild type revertant (WT -R) virus derived from L'l50luc (BAC+) was titrated in parallel with WT 
virus and L'l50luc (BAC+) on BHK-21 cells. Six well plates were seeded with BHK-21 cells 
overnight at 3 xl05 cells/ml, and infected at 5pfu/ml with either virus in 0.5ml media. An 
additional 2.5ml media was added to the input plate, which was frozen immediately. The 
remaining cultures were incubated at 3TC for an hour. The innoculum was removed from each 
plate, washed with IX PBS, followed by 1ml of O.IM citric acid wash for 2 minutes at room 
temperature to kill excess virus that had failed to penetrate the cells by that time. Citrate wash 
was then removed, and cultures were rinsed x2 with 2ml of warm media. 3ml of media was then 
added to cultures, and the t=O time point frozen immediately. The remaining cultures were 
incubated at 37°C and frozen at the appropriate time points at -70°C. Celllysates were then 
freeze thawed, and the amount ofvinis at each time point determined by plaque assay. 
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Genome Copy Number 
Medium purified virus stocks were titrated in parallel on the complementing Clone 11 cell line, 
and the non complementing BHK-21 cell line as previously described. 
200,..1 TE buffer (10mM Tris: 50mM EDTA p.H 8.0) was added to 3x50,..1 aliquots of virus 
stock. 25 ,..1 of 10% SDS and 1 ,..1 20mgmr1 proteinase K were added to samples, and incubated 
at 37°C overnight. Samples were sonicated for 2xlmin to generate DNA pieces 5-6Kbp in size. 
DNA was purified according to the Qiaquick PCR Purification kit protocol (Qiagen). 
Serial dilutions were performed on triplicate DNA samples, which were subjected to real time 
PCR on the Rotor Gene RG 3000 (Corbett Research) using TaqMan probes (Tib molbiol) and 
primer set for ORF9 as detailed in the RT-PCR methods sec.tion (Chapter 3) amplified alongside 
a standard curve. 
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RESULTS 
The goal ofthe current study is to establish a clean latency system in MHV-68 devoid ofiytic 
background infection. An IE deficient mutant was generated by deletion of the MHV -68 ORF50 
gene. The ORF50 gene was then replaced with the luciferase gene driven by the intact ORF50 
promoter. The ORF50 deletion mutant with luciferase under the ORF50 promoter, denoted 
~50luc, was used in experimental work. ~501uc provided the background for ~50IucgMGFP in 
which the late glycoprotein gM is fused to GFP resulting in GFP expression and subsequent 
green fluorescence in lytic infection [May et al, 2005]. Furthermore, the MHV-68 genome is 
contained within a BAC cassette, containing a human cytomegalovirus immediate early I 
(HCMV IE) promoter driving GFP expression [Adler et al, 2000]. Thus WT and ~50mutants 
express GFP from the BAC. BAC negative mutants in which the 8.8kbp BAC vector sequence 
has been excised were also made. The characterization of these viruses is detailed. 
The L1501uc mutant contains no secondary mutations 
Cell mutagenesis procedures can introduce secondary mutations. Therefore, a selected mutant 
may contain other mutations than the desired ORF50 deletion mutation as r~combination events 
in eukaryotes are difficult to control [Messerle et al, 1997]. It is therefore only possible to verify 
appropriate reconstitution of the designed mutation after growth and isolation of the constructed 
VIruS. 
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WT revertant virus generated by reverse mutation of il50Iuc(BAC+) showed identical growth 
kinetics to WT virus in a single step growth curve, indicating that the ORF50 deletion had been 
successfully engineered, and that no additional mutations had been acquired which could 
contribute to the mutant virus phenotype. The il50tuc (BAC+) virus was unable to replicate on 
non complementing BHK-21 cells (Figure 5). 
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Figure 5 
Growth Curve showing Kinetics ofWT, WT-revertant and Ll50luc (BAC+) replication over 48 
hours. Non complementing BHK-2 1 cells were infected with either virus at 5pfu/cell, and 
harvested at the appropriate time points. Titres at each time point were determined by plaque 
assay. 
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The LJ50luc (BAC+) and LJ50lucgMGFP (BAC-) null mutants are replication defective but . 
recover growth characteristics on complementation 
A growth curve comparing WT virus to 1l.50 viruses in the complementing clone 11 cell in the 
presence of 1 mg/ml doxycycline showed that the 1l.50 mutants were able to recover replicative 
fimction, with no deviation from the WT virus growth pattern in a single step growth curve 
(Figure 6) . In the absence of doxycycline, the t,50 mutants eventually underwent lytic 
replication, although full complementation did not occur within the 48 hour time course. This 
result indicates that the clone 11 cell line has leaky ORF50 expression, although induction with 
doxycycline is needed for full complementation. 
38 
Figure 6 
Growth Curve showing Kinetics ofWT versus ~50Iuc(BAC+) and ~50IucgMGFP (BAC-) over 
48 hours. 
Complementing clone 11 cells supplying ORF50 in trans were infected with 5pfu/cell of 
L150Iuc(BAC+) and L150IucgMGFP(BAC-) and harvested at the appropriate time points. Titres at 
each time point were determined by plaque assay. 
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48 
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I lI50IucgMeGFP(BAC-)-dox 
WTreversionfrequency is below I WTrevertant per 10 5 pfu 1150 in most 1150 stocks 
WT reversion frequency was determined by plaque assay. Briefly, BHK-21 cells seeded at 1 x 10 
7 cells/flask and grown overnight, were infected with 10 5, 104, 10 3 or 102 pfu of each virus stock. 
Infected cultures were incubated with 1 % CMC to prevent plaque confluence, and observed for 
green fluorescence and plaque formation over 5 days. The number of plaques seen was divided 
by the pfu of virus delivered and multiplied by 100 to give the % WT contamination listed in 
Table 4. With the exception of b,50IucgMGFP(BAC-), all stocks were BAC +, and areas of 
plaque formation showed clusters of green fluorescent cells, due to stimulation of the BAC 
.derived HCMV-IE resulting in GFP expression during productive infection. No GFP negative 
plaques were seen in the light phase, in either BAC + virus stocks or b,501ucgMGFP(BAC-). In 
some b,50 BAC+ stocks, some single green cells were seen, without plaque formation or CPE. 
The HCMV-IE promoter can also be stimulated resulting in GFP expression from latent genomes 
possessing the BAC cassette. To determine whether these single green cells represented latent or 
lytic infection, supernatant from b,50 infected cultures was placed on to fresh, uninfected BHK-
21 cells and followed for plaque formation. Only lytic virus is infectious, thus the ability to infect 
fresh BHK-21 cells would confirm the presence of contaminating WT virus in the original b,50 
infected culture. 
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Frank CPE accompanied by plaque formation was seen only in the WT control, and in highly 
contaminated stocks which were discarded, with 4 and 8 % WT contamination in media purified 
(MP) and cell associated (CA) stocks respectively. In general, CA stocks showed higher 
reversion frequency than MP stocks. Most stocks showed less than I in 105 pfu WT virus 
contamination. The Li50lucgMGFP (BAC-) stock showed neither plaque formation nor green 
fluorescence. <".50lucgMGFP (BAC-) provided the most rigorous screen of the <".50 mutant 
stocks, as any GFP expression in this stock where GFP is fused to the late gM glycoprotein, 
must identify virus late gene expression oflytic infection as a result ofWT contamination. 
Only media purified stocks with <I in 105 WT contamination were used in subsequent 
experiments, and assays were set up to deliver under 1 in 105 pfu/ml of <".50 virus stock to 
minimize the possibility of delivering WT contaminating virus. 
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Table 4 
Reversion frequency in 6.50 virus stocks detennined by plaque assay. 
Number of plaques seen by 5 d.p.i in BHK-2l cells infected with 6.50 stocks at 102 , 103' 104 or 
105 pfu/flask and overlaid with 1 % CMC are listed and used to determine the % WT 
contamination. Appearance of 6.50 ' plaques ' compared to WT plaque are shown on the right 
hand side. 
Virus Number of plaques Passaged % WT 
infectivity contamination 
Wild type (bac +) TMTC* YES WT 
650luc(bac +) Media Purified 40 in 10""3 YES 4% 
Stock 1 
650luc(bac +) Cell Associated 78 in 10~3 YES 8% 
stock 1 
650luc(bac +) Media Purified 1 in 10"5 NO 0.001% 
Stock 2 
650luc(bac +) Cell Associated 5 in 10 AS YES 0.005% 
Stock 2 
650gMGFP Media Purified 1 in 10 1\5 NO 0.001% 
(BAC +) 
650gMGFP Cell AssoCiated lin 10 1\5 NO 0.001% 
(BAC +) 
650gMGFP Media Purified 0 NO 0% 
(BAC -) 
650gMGFP Cell Associated 0 NO 0% 
(BAC -) 
* TMTC denotes too ITlany plaques to count . 
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L150 viruses in complementing clone 11 cells have a high particle: pfu ratio comparable toWT 
virus in non complementing BHK-21 cells 
To further characterize the viruses, the genome copy number delivered to each cell during lytic 
infection was determined. Viral DNA was extracted from equal volumes of media purified virus 
stocks. To ensure accurate calculations, the same stock pot used for DNA extraction, within the 
same thawing, was used to perform duplicate titrations of all viruses in parallel with one another, 
on complementing clone 11 cells for both WT and L'..50 viruses, and on BHK-21 cells for WT 
viruses for comparison. 
The number of genome copies assessed by real time PCR was divided by the titre of virus in the 
original volume of DNA extracted, to give the number of genomes delivered per cell, compared 
to the number of viral plaque forming units. This gave the particle: pfu ratio, a measure of the 
proportion of defective: infectious viral particles for each virus. 
The L'..50IucgMGFP(BAC-) virus had the highest genome copy number at log 103.4, suggesting 
a high ratio of defective to infectious virions. L'..50IucBAC+ also showed a high particle: pfu ratio 
at log 102.1 compared to WT virus in the complementing clone 11 cell line. In the non 
complementing BHK-21 cell line however, WT virus showed a comparable particle: pfu ratio to 
that shown by the L'..50 viruses in Clone 11 cells (Figure 7). 
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Figure 7 
Real time-PCR was conducted on triplicate aliquots of viral DNA using primers specific to the 
ORF9 gene. WT and L'.50 viruses were titrated in parallel on the complementing Clone II cell 
line, and WT virus compared on the non complementing BHK-21 cell line. The genome copy 
number was determined by dividing the DNA copies obtained by RT-PCR by the viral 
pfu/aliquot, determined by titration in BHK-21 and Clone II cells. The mean and standard error 
is shown for two independent biological experiments. 
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o 1I50IucGMGFP(BAC-) 
11I501uc+ 
OWT(BAC+) 
oWT(BAC-) 
gMfused GFP localizes to the perinuclear membrane, while BAC derived GFP is pancellular 
Confocal imaging provided high resolution images of infected cells, enabling localizaton of the 
GFP in the different Teporter constructs. BAC derived GFP was found throughout the cell, in 
both WI virus and in L150 virus containing the BAC cassettes, while gM fused GFP localizes to 
a perinuclear location, a pattern consistent with gM localization to golgi membranes [Mach et ai, 
2000] ; [May et ai, 2005]. 
45 
Clone 
11 
24 h.p.i 
Figure 8 
Clone 11 cells were seeded in the presence of 1 mg/ml of doxycycline in individual wells, and 
infected with 1 pfu/cell of either a) i1501uc (BAC+), b) i150IucgMGFP (BAC-) or c) WT (BAC+) 
virus. Cells were imaged at 24 h.p.i in the green fluorescence phase. 3D Confocal Image stacks 
of single cells were generated using the Leica Confocal Imaging Software. 
i1501uc (BAC+) i150IucgMGFP (BAC-) WT 
" 
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DISCUSSION 
The 650 latency system provides a means by which latency can be established in vitro and key 
questions addressed regarding latency. Fundamental to its design is the absence oflytic 
competent virus from 650 mutant stocks, as this has confounded other latency systems [Sunil-
Chandra et ai, 1992) ; [Usherwood et ai, 1996). A previous 650 mutant has been described, with 
1 pfu WT revertant present in 3 xlO 4 pfu to I xlO 5 pfu 650viral stock [Pavlova et ai, 2003), The 
650 mutant used in that study was generated by incorporating a TAG stop codon at bp 67975, 
and contained significant 5' and 3' sequences overlapping with the ORF50 sequence in their 
ORF50 complementing cell line, contributing to WT reversion. In generating an ORF50 deletion 
mutant, the Efstathiou laboratory was able to limit overlap to 172bp at the 5' end and 196 bp at 
the 3' end without threatening the integrity of the adjacent ORF49 and M7 genes (Figure 9). As 
the potential for recombination occurred with each passage through the ORF50 complementing 
Clone II cell line, making stocks to submaster was a compromise which limited the opportunity 
for wild type reversion while generating sufficient viral stocks for experimentation. In this 
system which had the sensitivity to detect I WT revertant in 10 5 pfu of 650 virus, no WT 
contamination was detected in the 650IucgMGFP(BAC-) stock, and I WT revertant in 10 5 pfu 
of 65OJuc(BAC+) stock. 
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Figure 9 
Schematic Diagram Showing Overlapping between the ORF50 contributed by the Clone 11 cell 
line, and the 5' and 3' fragments remaining after deletion ofORF50 in the Ll.50 mutant. 
a) ORF50 in the Clone 11 cell Line 
ATG A TG from exon 1 on splicing 
r r 
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The determination of WT reversion frequency in I'>.SO stocks relied on the expression of GFP 
from viral genomes in the non complementing BHK-21 cell line. This cell line was used rather 
than the non complementing 3T3 cell line as all titres for WT stocks had historically been 
obtained on BHK-21 stocks and infection well characterized in this cell line. The I'>.SO mutation 
confers a plaquing deficit on the MHV -68 virus as plaque formation represents focal areas of 
productive infection in cell culture. Thus, screening BHK-21 cultures infected with 1'>.50 in the 
anticipated experimental range of 1 02 to 105 pfu for plaque formation provided a good estimate of 
WT reversion frequency. Given the observation that GFP expression from BAC sequences may 
represent activation of the HCMV promoter in latent or lytic infection [Rosa et ai, 2007], areas 
of GFP fluorescence were counted as plaques, even in the absence oflocal CPE in estimating 
reversion frequency. Thus, a reversion frequency of 1 x 10 5 in the I'>.SOluc(BAC+) stock is likely 
an overestimate, however all experiments using the I'>.SOluc(BAC+) stock were designed to 
deliver under 105 pfu of virus, as the absence of WT virus from latent cultures was fundamental 
to the design of this latency system. 
Virus entry and lytic replication varies between cell lines [Bemfield et ai, 1999]. While WT 
viruses are grown in BHK-21 cells, the kinetics of viral growth between 1'>.50 and WT virus 
growth were compared in the 3T3 fibroblast ORF50 complementing cell line clone 11. The fact 
that I'>.SO and WT virus attained the same growth peak in a high multiplicity growth· curve, not 
only indicated that ORFSO supplied in trans fully complemented 1'>.50, but that even WT virus 
had some additional ORFSO requirement for maximal lytic infection. 
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WT virus showed very disparate particle: pfu ratios between complementing and non 
complementing cell lines of approximately 10gIO 2.5 and log 10 1 respectively, suggesting that 
some portion of cells infected by WT virus were entering latency on infection of BHK-2I cells, 
but failed to enter latency in the presence of ectopic ORF50 supplied by the clone II cell line. 
The high particle: pfu ratio exhibited by il50IucgMGFP(BAC-) virus suggests a higher 
proportion of defective particles than other viral stocks. A role has been identified for defective 
viral particles in modulating virulence [Cave et ai, 1985] ; [Browning et ai, 1991]' The 
implication of this result is that infections with il50IucgMGFP(BAC-) may require up to 10 fold 
higher virus titres to il50Iuc(BAC+). Ultimately, the reasons for differences in particle: pfu ratios 
in different viruses is unclear, and may indicate secondary mutations that don't impact viral 
growth kinetics, but affect infectivity. In order to discount this possibility, revertants of each 
mutant would need to be generated, with particle to pfu ratios that reverted to WT. 
By design, the il50 latency system relies on GFP expression to visually detect infection. Given 
the ambiguity in determining whether green fluorescence indicates lytic or latent infection in 
BAC positive stocks, it was useful to characterize GFP expression, and confirm the perinuclear 
co-localization of gM and GFP, confirming the association of GFP expressi~n with lytic 
infection in il50lucgMGFP(BAC-). 
With a characterization of the il50 mutants and comparison to the WT MHV -68 phenotype, it 
was possible to proceed with an exploration of latency. 
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CHAPTER 2 
ESTABLISHMENT OF LATENCY BY A50 MHV-68 
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METHODS 
Luciferase Assay 
3I3 cells and clone 11 cells were seeded at 5 x104 cells/well in a six well plate, in the presence 
of 1 mg/ml for clone 11 cells. Cells were grown overnight to 70% confluence and were infected 
with either t.50luc (BAC+) or WI virus (BAC+) at an MOl of 0.1 or 1, and harvested 24 h.p.i. 
Cultures were washed 2x with PBS, and 400J.lI oflysis buffer added. After 10min, supernatant 
was collected into tubes and centrifuged at 5,000 rpm for 1 min. 386J.ll ofluciferase assay buffer 
and 100J.lI of cell supernatant or lysis buffer for the negative control added to assay tubes. 
Luciferase assays were performed using the automated Luminometer (Berthold). Buffers used 
are listed in Appendix L 
Latency Experiments 
3I3 cells or clone 11 cells were seeded as above, and infected with 0.1 , I or 5 m.o.i of t.50luc 
(BAC+), t.50IucgMGFP (BAC-) or I m.oj WI (BAC+) virus in the various assays. Cells 
were followed over the course of24 hours for GFP expression determined by observing green 
fluorescence by fluorescence microscopy. In order to quantify the amount of GFP expression, 
latently infected cultures were reactivated and compared to mock infected (media) samples for 
green fluorescence by flow cytometric analysis on days 1,2 and 3, 7, 15, or 30 days post 
infection. For 30 day experiments, cells were passaged every four days. For reactivation, 
200J.lg/ml phosphonoacetic acid (PAA) was added to cu.1tures prior to super-infection with WI 
(BAC-) virus at 5pfu/cell. 
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20h post super-infection, cultures were analysed for GFP fluorescence, and the proportion of 
GFP expressing cells in reactivated versus un-reactivated cultures compared by flow cytometry. 
A similar protocol was utilized for infections in non-pe=issive RAW cells with the modification 
that virus was pre-incubated lh prior to infection and titrated with the IgG gp150 specific 
monoclonal antibody, TlA1, from BALB/c mice intra-nasally infected with MHV-68 (2 x10 4 
pfu). Infections were carried out at 0.1, 1 and 5 m.oj of the ~50 viruses in the various assays, 
and LPS at 100nglml added to cultures 3h prior to flow cytometry as LPS stimulates the HCMV 
-IE promoter, revealing the cohort of cells infected with BAC+ virus. To titrate T1A1, aliquots 
ofWT (BAC+) virus were incubated with serial dilutions ofT1A1 and used to infected 3T3 cells 
at 1 pfu/cell. WT infected cultures were imaged at 24 h.pj in the presence of LPS. The dilution 
ofT1A1 that gave the highest proportion of green fluorescent cells, was used from then on for 
pre-incubation to potentiate virus for RAW macrophage infection. 
Flow Cytometry 
Cells were harvested at the appropriate time points by removing media, washing with 1ml PBS, 
and trypsinization for 3T3 cells, and scraping into 1ml fresh media for RAW macrophages. Cells 
were pelleted by centrifugation at 1500 rpm IEC 6000B rotor for 3112 minutes, and re-suspended 
at 1 x 10 6 cells/ml in 1 % BSA in 5ml round bottom tubes. Samples were assayed for green 
fluorescence on a FACS Calibur using WNMDI software. 
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RESULTS 
Latency in 3T3 Fibroblasts 
A reporter system to detect contaminating lytic virus 
Initial experiments using the luciferase reporter system yielded very low counts for luciferase in 
the WT and complemented case, with no clear pattern between latent and lytic samples. The 
t.SOluc (BAC+) mutant was subsequently sequenced, and it was found that the luciferase gene 
was cloned out of frame. Sequencing confirmed that the t.SO mutation was intact (Coleman, 
personal communication). Initial growth curves indicated that no secondary mutations had been 
introduced, and that supplying ORFSO in trans fully complemented the t.SO mutation (Figure S & 
6). Luciferase expression could thus not be explored as a marker oflytic infection, however the 
integrity of the t.SO mutation in the t.SOluc mutant was conserved, and this mutant was used for 
further experimentation. An alternative reporter system based on OFP expression was thus 
explored. 
The MHV-68 genome is maintained within a BAC, enabling targeted mutagenesis. The BAC 
cassette contains OFP under the strong HCMV-IE, which is activated by viral transcription 
activators and cellular transcription factors, and is thus expressed during lytic infection. OFP 
expression from the BAC cassette indicates that the viral genome is transcriptionally active, and 
has previously been used as a convenient marker oflytic infection [Adler et ai, 2000] ; [Moser et 
ai, 200S]. 
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In the complementing cell line, lytic infection in Ll.50 infected cultures appeared similar to WT 
infected cultures with respect to green fluorescence and plaque formation, consistent with their 
similar growth kinetics (Figure 6). In the non complementing 3T3 cell line, reactivated Ll.501uc 
(BAC+) cultures looked very similar to WT infected cultures with green plaques seen, while un-
reactivated Ll.501uc (BAC+) cultures showed single green cells, but no plaque formation (Figure 
10). This result indicated that green fluorescence provided a good visual screen oflatent versus 
lytic infection in Ll.50 infected cultures. Green fluorescence in Clone 11 cells infected with 
Ll.501uc (BAC+) without doxycycline was ambiguous as the sparse green fluorescence could 
either reflect latent infection or a slower lytic infection due to leaky ORF50 expression, as seen 
in Figure 6 (Figure 10). 
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Figure 10 
Complementing Clone 11 cells seeded in the absence (-dox) or presence (+ dox) of Imglml of 
doxycycline, and non complementing 3T3 cells, were grown overnight. Cells were infected with 
1 pfulcell of i150luc (BAC +) or WT (BAC+) virus. At 12 h.p.i, a subset of i1501uc (BAC+) 
infected 3T3 cultures were reactivated by super-infection with 5 m.o.i ofWT (BAC-) virus, to 
reveal latent i1501uc (BAC+). At 24 h.p.i, both un-reactivated and reactivated 3T3 cultures, and 
clone 11 cultures, were viewed under fluorescence microscopy. Phase contrast images are 
shown for negative control uninfected cultures while fluorescence images are shown for infected 
cultures, imaged at lOx magnification. 
56 
3T3 
24 h.p.i 
Clone 
II 
24 h.p.i 
Uninfected 
Uninfected 
Phase contrast 
unreactivated reactivated 
+ dox 
Green fluorescence 
57 
Recent studies have indicated that BAC derived GFP expression cannot reliably be used asa 
marker ofiytic infection, and occurs in some latently infected cells [Rosa et ai, 2007]. To 
eliminate ambiguity in determining whether ,1';.50 cultures were latently or Iytically infected, an 
alternative GFP based construct was designed by gMGFP fusion on the ,1';.50 background, with 
excision of the BAC vector sequences to generate ,l';.50IucgMGFP(BAC-) virus. This virus did 
not exhibit green fluorescence in 3T3 cells by 24 h.p.i, and phase contrast imaging showed no 
CPE or plaque fonnation. On reactivation of ,l';.50IucgMGFP(BAC-) infected cultures however, 
green fluorescence was seen with associated CPE and plaque fonnation, indicating that gM 
derived GFP is exclusively expressed during advanced lytic cycle, providing a superior marker 
of lytic infection. A fraction of cells in Clone II cultures infected with ,l';.50IucgMGFP(BAC-) 
without doxycycline were green indicating leaky ORF50 expression in this cell line, compared 
to overwhelming lytic infection in the presence of doxycycline (Figure 11). 
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Figure 11 
Complementing Clone II cells seeded in the absence (-dox) or presence (+ dox) of Img/ml of 
doxycycline, and non complementing 3T3 cells, were grown overnight. Cells were infected with 
1 pfulcell of b.50IucgMGFP(BAC -) or WT (BAC+) virus. At 12 h.p.i, a subset of 
b.50IucgMGFP(BAC-) infected 3T3 cultures were reactivated by super-infection with 5 m.o.i of 
WT (BAC-) virus, to reveal latent b.50IucgMGFP(BAC-). At 24 h.p.i, both un-reactivated and 
reactivated 3T3 cultures, and clone 11 cultures, were viewed under fluorescence microscopy. 
Phase contrast and fluorescence images are shown for infected cultures, and phase contrast 
images are shown for negative control uninfected cultures. Images are at lOx magnification. 
59 
3T3 Green 
Clone 
Fl uorescence 
Phase 
Contrast 
II Green 
Fluorescence 
Phase 
Contrast 
uninfected 
~50lucgMGFP(BAC-) 
unreactivated 
~50IucgMGFP(BAC-) 
reactivated 
~50IucgMGFP(BAC-) 
unreacti vated reactivated 
~50IucgMGFP 
no dox 
~5011lcgMGFP 
(BAC-) 
no dox 
60 
~50IucgMGFP 
+dox 
~50IucgMGFP 
(BAC-) 
~ 
+dox 
P AA at 200flgiml prevents viral spread 
While the HCMV IE promoter is active in some latently infected cells, the full cohort of latently 
infected cells do not express GFP during latency. Super-infection with WT (BAC-) virus at 5 
pfu/cell provides ORF50 to quiescent Li.50 mutant genomes in latently infected cells, resulting in 
coordinate reactivation oflatent cultures. In order to avoid overestimation of the proportion of 
latently infected cells by this method, rescued Li.50Iuc(BAC+) viral spread from cell to cell must 
be inhibited. PAA inhibits viral DNA polymerase [Honess et ai, 1977]. The efficacy ofP AA in 
limiting viral spread was tested as described in figure 12 which follows the development of a 
single plaque. Individual plaques were indistinguishable by 16h.p.i in the absence of P AA, 
indicating that replication competent WT virus is able to spread from cell to cell. In the presence 
of P AA however, a green cell noted at 4 hpi fails to develop into a plaque over 16h, as viral 
replication and subsequent spread is inhibited. 
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Figure 12 
Non complementing 3T3 cells, were grown overnight in a six well plate. Ih prior to infection, 
200flg/ml PAA was added to a subset of3T3 cell cultures. Both cultures without PAA, and 
cultures containing 200flg/ml P AA were then infected with 0.1 pfu/cell of WT (BAC+) virus. 
Infected cultures were viewed by fluorescence microscopy, at 4,8 and 16 h. p.i. Fluorescence 
images are shown at 20x magnification 
A) - PAA 
4 8 16 
B) +PAA 
4 8 16 ~ 
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Latency can be established and maintained/or at least 3 days in 3T3jibroblasts 
These preliminary studies outlined a protocol for interpreting GFP reporter gene assays, for 
establishing latent infection, and reactivating latent genomes. I thus proceeded with 
characterizing latent infection with Ll.501uc (BAC+) in the 3T3 fibroblast cell line as described in 
Figure 13. 
The HCMV-IE promoter shuts off in the majority oflatently infected, un-reactivated cells over 
the 3d time course, however a small proportion of cells remain green (13a). This may be due to 
a cohort of cells in which the HCMV-IE promoter remains constitutively active, or changing 
populations of cells in which the HCMV-IE promoter turns on and off. On super-infection, a 
much greater number of cells are revealed to be latently infected (13b). The 12 h time point (l3bi) 
appears too early to capture the full cohort oflatently infected cells, while cell death has begun to 
occur by 48h (l3biii). Thus in all future experiments, reactivated cultures are imaged at 24 h post 
reactivation (13bii). 
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Figure 13 
Non complementing 3T3 fibroblasts were infected with I pfulcell of t.50luc(BAC+) in the 
presence of PAA. Cultures were followed for 3d, with super-infection with 5 pfulcell of WT 
(BAC-) in a subset of latently infected cultures, at either 1,2 or 3d.p.i to reactivate cultures. 
Cultures in which a) no reactivation occurred, and cultures b) reactivated at I, 2 or 3 d.p.i are 
compared at each time point. Following reactivation, cultures were imaged bi) 12, bii) 20 or biii) 
48 hours after reactivation, to determine the appropriate time to visually capture the full cohort of 
green fluorescing cells. Fluorescence images are shown at 4x magnification. 
I 2 3 
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The same protocol was applied for latency experiments using MOlucgMGFP(BAC-) with the 
caveat that no P AA was used (Figure 14). Given that gM is a late gene product the expectation 
was that gM GFP expression would not be observed in cells infected in the presence ofPAA as 
PAA blocks DNA replication and subsequent late gene expression. In this scenario, the 
proportion of latently infected cells may be overestimated, compared to L\.50Iuc(BAC+), as viral 
spread from cell to cell can occur in the absence of P AA. 
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Figure 14 
Non complementing 3T3 fibroblasts were infected with 1 pfu/cell of 
.t.50lucgMGFP(BAC-) in the absence ofP AA. Cultures were followed for 3d, with super-
infection with 5 pfu/cell ofWT (BAC-) in a subset oflatently infected cultures, at either 1,2 or 
3d.pj to reactivate cultures. Cultures in which no reactivation occurred, and cultures reactivated 
at 1,2 or 3 d.p.i are compared at each time point. Following reactivation, cultures were imaged 
20 hours post reactivation. Fluorescence images are shown at 20x magnification 
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1150Iuc(BAC+) and 1150IucgMGFP(BAC-) have comparable reactivation efficiencies 
Fluorescence microscopy gave a visual estimate of the proportion of reactivated, and thus 
latently infected cells in culture. In order to quantify the efficiency of reactivation, 3T3 cell 
cultures were analyzed on a FACS machine for green fluorescence. Reactivation efficiency 
indicates the % of green fluorescence cells in a culture detected by flow cytometry, and implies 
the proportion oflatently infected cells that were able to be reactivated. The protocol used in 
analyzing samples is outlined in Figure IS. In order to assess the m.o.i of infection required to 
achieve latency in at least a third of cells in cultures, infections were conducted at 0.1, I and 5 
pfulcell of both viruses (Figure 16). 
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Figure 15 
A representative data set depicting the FACS analysis protocol. 
3T3 fibroblasts were infected at Ipfu/cell of Ll.50Iuc(BAC+), and reactivated by superinfection 
with WT(BAC-) at 5pfu/cell in the presence of P AA . The proportion of green fluorescent cells 
was dete=ined by FACS for (Un) un-reactivated and (R) reactivated cultures. 
The population of viable cells is selected according to size (forward scatter) and granularity (side 
scatter), and gated as Region I (Rl). In plots b-d, i), ii) and iii) correspond to uninfected, latently 
infected but un-reactivated(Un), and latently infected then reactivated (R.) respectively, which 
are all gated through Rl. The intensity of green fluorescence of cells is plotted against cell 
granularity (b). The regions containing auto-fluorescing versus green fluorescing cells are 
defined as R2 and R3 respectively, according to positive or negative deviation from the +450 
angle (c).The number of green cells within R3 was plotted against the range of fluorescence (d). 
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Figure 16 
3T3 fibroblasts were infected at 0.1,1, or 5 pfulcell of a) i1501uc gMGFP(BAC-) or b) 
i150Iuc(BAC+), and reactivated by super-infection with WT(BAC-) at 5pfulcell in the presence 
ofP AA for a) and in its absence (b). The proportion of green fluorescent cells was detennined by 
FACS for (Un) un-reactivated and (R) reactivated cultures. A background level of fluorescence 
in mock infected cells occurred in the green fluorescent range. This value was deducted from 
FACS values for all infected cultures. 
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For ~50lucgMOFP(BAC-), the background level of fluorescence observed in un-reactivated cells 
appears stable at <2%, and is attributed to autofluorescence of cells in R3 (Figure 16a). There 
appears to be a general increase in reactivated cells with MOlucgMOFP(BAC-) , which in the 
absence of P AA is likely due to viral spread. 
As previously seen, there was a decrease in the proportion of un-reactivated, latently infected 
cells expressing OFP over the 3 day timecourse, following infection at both 1 and 5 pfu/cell 
(Figure 16a) with ~50Iuc(BAC+). For both viruses at 5 pfu/cell, up to 65% oflatently infected 
cells were reactivated. At 1 pfu/cell up to 50% of ~50Iuc(BAC+) infected cells and 30% of 
~50IucgMOFP(BAC-) infected cells harbouring latent genomes were reactivated. 
In cultures infected with 5 pfu/cell of either virus, there was a significant drop in reactivation 
frequency in cells reactivated 3d.pj,. This was likely due t.o cell death, with loss of cellular 
adherence and disruption of the monolayer. Cell death did not occur in the cultures infected at 
0.1 or 1 pfu/cell reactivated by 3 d.pj. ~50luc(BAC+) cultures infected at 5pfu/cell are shown 
following reactivation 3 d.pj as an example (Figure 17). 
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Figure 17 
Phase contrast images for 3T3 fibroblasts from experiment 17a, infected with either 0.1, 1 or 5 
pfu/cell of L\.50Iuc(BAC+), and reactivated 3 days post infection. Images were taken 20h post 
reactivation at lOx magnification. 
3T3 
fibroblasts 
reactivated 
3d.pj 
0.1 1 5 m.o.i 
74 
Given the toxicity effect noted following infection at 5 pfu/cell ( Figures 16 & 17) and the low 
reactivation frequency observed following initial infection at 0.1 pfu/cell (Figure 16), further 
latency experiments in 3T3 fibroblasts were conducted at 1 pfu/cell. 
1150IucgMGFP (BAC-) and LJ50Iuc(BAC+) infected cultures are able to maintain a stable latent 
state for at least 30 days 
To ascertain the stability of latency following infection of cells with an ORF50 deletion mutant, 
latently infected cultures were followed over 30 days (Figure 18). The level of background auto-
fluorescence in t:.50lucgMGFP (BAC-) infected cultures remained stable at 1-2 % over the 30d 
time course, indicating the absence of contaminating lytic virus. On reactivation by super-
infection with 5 pfu/cell ofWT(BAC-), it was revealed that up to 37.6+/-6 % of cells harbour 
latent genomes (Figure 18a). 
Figure 18b shows that the HCMV -IE promoter remained active in up to 14.2 +/-1.6% of cells 
infected with t:.50luc(BAC+). On reactivation, up to 47.4 +/-9.3 % of cells fluoresced green, 
approximately 10% higher than t:.50IucgMGFP (BAC-) infected cultures which is likely due to 
'. 
differences in partic1e/pfu ratios between viral stocks (Figure 7). In the first 3d.p.i, the 
proportion oflatently infected cells in which the HCMV -IE promoter is active initially decreases 
as seen in Figure 16, but remains stable over the 30d time course. The absence of increasing 
numbers of green cells in un-reactivated cultures indicates the absence of spontaneously 
reactivating virus. 
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There is some variation in the number of green cells on reactivation over the time course with a 
slight increase at the 15 and 30d time points. This is likely due to small differences in viral pfu 
delivered over the 3 independent experiments. A steady increase in the proportion of green cells 
in P AA treated infected cultures, without reactivation, is noted. This may be due to a stimulatory 
effect ofPAA on the HCMV-IE promoter resulting in GFP expression, or may represent a 
reactivating effect ofPAA on latently infected virus. 
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Figure 18 
3T3 cells seeded at 5 x 104 cells/well were infected with either a)t.50luc gMGFP(BAC-) or 
b )t.50Iuc(BAC+). These cultures were passaged every four days. Briefly, cells were detached 
from monolayer with trypsiniEDTA, pelleted and resuspended in Imll0% DMEM. These 
latently infected cells were counted, and seeded at 5 x 104 cells/well in fresh six well plates. Each 
assay was performed in triplicate. Reactivation with 5 m.oj ofWT(BAC-) in the absence of 
PM for a) and in its presence (b), occurred at 1, 2,3,5,7,15, and 30 days post infection. The 
proportion of green fluorescent cells was determined by FACS for un-reactivated and reactivated 
cultures at each time point. A background level of fluorescence in mock infected cells occurred 
in the green fluorescence range. This value was deducted from F ACS values for all infected 
cultures. 
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Latency in RAW Macrophages 
While permissive 3T3 fibroblasts were appropriate in the initial characterization ofthe 1\.50 
latency system, the actual sites oflatency in vivo are primarily B lymphocytes, with latency also 
occurring in macrophages and dendritic cells. Thus, the next step was to explore latency 
establishment and maintenance in non permissive RAW macrophages and NSO B cells. 
Rhadinqvirus attachment into cells is mediated by glycosaminoglycans (GAGs), hetero-
polysaccharides expressed on some cell surfaces, and facilitating viral entry by providing a site 
for reversible attachment [Shukla et ai, 2001]. 3T3 fibroblasts represent a permissive cell line, in 
which GAGs are abundantly expressed, and viral entry is efficient. In contrast, RAW 
macrophages and NSO B cells represent relatively GAG deficient non permissive cell lines 
[Bemfield et ai, 1999]. 
The immune response to viral infection involves antibody mediated neutralization of virus to 
prevent binding to cell receptors [Fink et ai, 2006] ; [Knossow et ai, 2006]. Recent studies have 
shown that neutralizing antibody inhibits infection of fibroblasts, but binding to Immunoglobulin 
receptors (IgFcR) on macrophages by antibody coated MHV-68 can still occur, and actually 
enhances viral infection in these cells. The enhancing effect is greatest with antigp150 antibody 
[Rosa et ai, 2007] ; [Iankov et ai, 2006]. Gp150 is a transmembrane glycoprotein encoded by the 
ORF, M7 [Stewart et ai, 1996]. It is unclear whether this is a means by which MHV-68 
circumvents the immune system, or whether the enhanced infection of immune cells is actually 
part of immune activation and the host defense mechanism. 
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A proposed mechanism for gp 150 action is to provide a cue for viral entry by weakly associating 
to GAGs on the cell surface. The major GAG binding protein is gp70, which is thought to bind 
soluble GAGs, thus hindering the premature association of gpl50 with GAGs. Gpl50 binding to 
GAGs induces a conformational change, resulting in viral adsorption and entry [Gillet et ai, 
2007]. Furthermore, MHV-68 down-regulates GAG expression in already infected cells, as GAG 
binding to gpl50 inhibits virion release [Souza et ai, 2004]. The fact that neutralization of gpl50 
enhances infection in GAG deficient macrophages and dendritic cells, and that a gp 150 deficient 
mutant has enhanced infection in B cells presents a conundrum, and suggests that GAG 
independent mechanisms of viral entry may occur in these cell types. IgFcR mediated 
enhancement of macrophage infection can however be exploited for in vitro assays in this cell 
type. 
The preceding studies in 3T3 fibroblasts noted that HCMV-IE promoter activity is an unreliable 
marker ofiytic or latent infection. Lippopolysaccharide (LPS) has been shown to strongly 
activate the HCMV-IE promoter in RAW macrophages [Lee et ai, 2004]. In order to enhance 
infection, 11-50 virus was incubated with TlAI antibody for I h at 37°C, and the antibody coated 
virus used to infect RAW macrophages. On reactivation, WT (BAC-) virus at 5 m.oj was 
incubated with TIAI, and then used to super-infect cultures. Given the non permissive nature of 
infection, in the absence ofTIAI antibody pre-incubation, P AA was not required. 100ng/ml LPS 
was added 3 hours before fluorescence imaging and flow cytometric analysis (Figure 19). 
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Figure 19 
Schematic Representation of Infection and Reactivation Protocol in RAW macrophages. 
(t.dSO virus + antigplS0antibody) 
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RAW macrophages 
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LPS at 100ng/ml reveals a greater proportion of the cells harbouring the MHV-68 genome 
Initial experiments to demonstrate the efficacy of LPS in revealing the cohort of latently infected 
cells were conducted using this infection and reactivation protocol (Figure 20). 
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Figure 20 
Raw macrophages were infected at! m.o.i with either ~SOlucgMGFP(BAC-) virus or 
~SOluc(BAC+) pre-incubated with gp!SO antibody. ! day post infection, cells were reactivated 
with with Sm.o.i WT (BAC-) pre-incubated with gp!SO antibody. Cultures were imaged 20 h 
post reactivation, in the absence or presence of ! OOng/m! of LPS 
added 3h prior to F ACS. 
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In the presence of LPS, a greater proportion of the latently infected cells were revealed, for· both 
viruses, thus LPS was used in all further experiments in RAW macrophages. While this result is 
expected for the BAC+ mutant, it indicates that LPS has other actions on the MHV-68 genome 
beyond stimulation of the CMHV-IE BAC cassette, which is absent in LI.50IucgMGFP(BAC-). 
As with 3T3 cells, 3 day latency experiments were conducted at MOl's corresponding to 1 and 5 
pfulcell for both viruses, to assess the moi required to achieve latency in at least a third of cells in 
culture (Figure 21). Given the non permissive nature ofRA W infection, an m.o.i of 0.1 was not 
used. 
The CMV-IE appeared to turn off over time over the 3d time course even in the presence ofLPS 
with un-reactivated L'l.50luc(BAC+) (Figure 21b). Generally, there was an increase in the 
reactivation efficiency for both viruses over the 3 day time course. The highest reactivation 
efficiency was seen at an m.o.i of 5 for both viruses, without the toxic effect noted by day 3 in 
3T3 cells (Figure 16). Both the delay in peak reactivation frequency, and the lack of a toxic 
effect at 5 m.o.i are likely due to a reduced infectivity ofRA W macrophages with virus, even 
with viral potentiation by gp 150 antibody. Thus an m.o.i of 5 was used for further experiments. 
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Figure 21 
RAW macrophages were infected at 1 or 5 pfulcell of a)~50Iuc(BAC+) or b )~50luc 
gMGFP(BAC-) pre-incubated with TIAI antibody. At 1,2 or 3 days post infection, cells were 
reactivated with with 5m.oj WT (BAC-) pre-incubated with TlAI antibody. The proportion of 
green fluorescent cells was determined by flow cytometry 20h post reactivation for (Un)un-
reactivated and (R)reactivated cultures, with IOOng/ml LPS applied to cultures 3h before flow 
cytometry . A background level of fluorescence in mock infected cells occurred in the green 
fluorescent range. This value was deducted from FACS values for all infected cultures. 
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To assess the stability of latent infection, cells were infected with either ~50 virus and followed 
over 30 days (Figure 22). 
The peak reactivation efficiency in ~50luc(BAC+) and ~50IucgMGFP(BAC-) cultures was 
58.54%+/- 7.82 and 51.53% +/- 1.07 respectively. There was an increase in the reactivation 
efficiency for both viruses in the first three days of infection, which was however stable over the 
30 days, indicating episomal maintenance oflatent genomes. 
The increase in green fluorescence seen in the first 15 days of infection with 
~50lucgMGFP(BAC-) lacks the exponential quality of contaminating lytic infection, and is 
likely due to auto-fluorescence, increasing somewhat as the cells grow older, despite application 
of fresh media every four days on passaging (22a). 
In the first 3 days of ~50Iuc(BAC+) infection, there is a decrease in green florescence in Ull-
reactivated cultures, and then an increase at 7 days. This likely reflects stimulation of the 
HCMV -IE promoter during the change in environmental conditions imposed by passaging on 
day 7 (every 4 days with day 0 being the first passage), and is in a similar range to day I (22b). 
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Figure 22 
RAW macrophages were infected at 5 pfu/cell of a)L':.50IucgMGFP(BAC-) or b) L':.50Iuc(BAC+) 
pre-incubated with gp 150 antibody. Cells were passaged every four days in the same manner as 
3T3 cells (Figure 1) with the exception that cells were detached from the monolayer by scraping 
into media. Each assay was performed in duplicate. At 1, 2,3,7, 15 or 30 days post infection, 
cells were reactivated with 5m.oj WT (BAC-) pre-incubated with gp 150 antibody. The 
proportion of green fluorescent cells was determined by flow cytometry 20h post reactivation for 
un-reactivated and reactivated cultures at each time point, with 100nglrnl LPS applied to cultures 
3h before flow cytometry. A background level of fluorescence in mock infected cells occurred in 
the green fluorescent range. This value was deducted from FACS values for all infected cultures. 
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Latency in NSO B cells 
t150Iuc(BAC+) has a reactivation efficiency of only 2% using the established protocol 
MHV -68 infects B cells with low efficiency [Bemfield et ai, 1999]. Unlike macrophage infection 
however, antibody treatment does not enhance infectivity of B cells, nor does LPS reveal latently . 
infected cells (Stevenson, personal communication). To examine latency in B cells, the protocol 
of Ll.50 infection followed by reactivation was employed at high m.oj, comparing the BAC+ 
viruses, M7 stop mutant (Ll.M7, BAC+)and WT(BAC+) virus to Ll.50Iuc(BAC+) as positive 
controls. BAC+ viruses were used so that they could be directly compared for green fluorescence 
over the time course. Ll.M7 was used as a positive control as this mutant has an enhanced ability 
to infect B cells [de Lima et ai, 2004]. WT (BAC+) was used to determine whether the 
D.50Iuc(BAC+) had any greater deficit over WT in infecting B cells. Reactivation by WT (BAC-) 
virus superinfection at 5 pfulcell was performed 48 h.pj and samples analyzed for GFP 
expression by flow cytometry. 18% of Ll.M7(BAC+) infected cells and 11 % ofWT(BAC+) 
infected cells were reactivated, whereas only 2% of Ll.50Iuc(BAC+) cells were reactivated 
(Figure 23). The protocol applied to 3T3 fibroblasts and RAW cells could thus not be 
extrapolated to B cells which have a low efficiency of infection, limiting both infection and 
reactivation efficiency. Furthermore, B cells are preferentially latently infected, thus WT (BAC-) 
virus used for super-infection, is likely to go latent, and fail to reactivate quiescent genomes. 
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Figure 23 
Comparison of green fluorescence in NSO cell cultures infected with either L'.50luc(BAC+) at 
1,3,5, 7 or 10 pfulcell, WT(BAC+) at 3, 5 or 7 pfulcell or L'.M7 (BAC+) at I and 3 pfulcell. 
Given the poor infectivity ofB cells, a range ofmoi ' s was used to determine how much virus 
was needed to infect a substantial population of B cells. Latently infected cultures were 
reactivated at 48 hours post infection, by infection with 10 pfulcell of WT (BAC-). Cells were 
imaged 20h post reactivation by fluorescence microscopy and analysed by flow cytometry for 
green fluorescence. A background level of fluorescence in mock infected cells occurred in the 
green fluorescent range. This value was deducted from F ACS values for all infected cultures. 
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L15 Oluc(BA C + ) populations have low, variable GFP expression profiles even after FA CS sorting 
In order to examine latency in NSO B cells, FACS sorting was utilized to generate enriched 
populations of infected cells. NSO cells were infected at 10 pfulceU with D.50Iuc(BAC+), and 
sorted 48 h.p.i into GFP positive and GFP negative populations (Fignre 24). FACS sorting 
revealed that 2.7% of cells expressed GFP, with enrichment to generate a population where 95% 
of cells were GFP positive. These populations were followed over the course of 14 days by 
fluorescence microscopy, and FACS analysis was used to measure GFP expression 7 and 14 
days following sorting. By 7 and l4dpi, 23% and 16% of the initially GFP positive population 
fluoresced green, while 3% and 7% of the initially GFP negative population showed green 
fluorescence. Thus HCMV-IE promoter expression was variable, but low, in both the GFP 
positive and GFP negative sorted populations over time (Figure 25). 
" 
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Figure 24 
FACS Sorting ofNSO cells infected with t.50luc(BAC+) at 10 pfu/cell and sorted 48 h.p.i. PI is 
the region containing the sorted population of cells to achieve 95% of GFP positive cells (P3). P2 
represents the GFP negative population sorted, while Not PI shows the unsorted population. 
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Figure 25 
NSO cells were infected at 10 pfu/cellwith L'>50Iuc(BAC+), and sorted 48 h.p.i into GFP positive 
and GFP negative populations on day 0, with 95% of cells in the GFP population fluorescing 
green, and no green fluorescence noted in the GFP negative population. Cultures were then 
subjected to flow cytometric analysis for green fluorescence at 7 and 14 days post infection. A 
background level of fluorescence in mock infected cells occurred in the green fluorescence range. 
This value was deducted from FACS values for all infected cultures. 
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In summary, latency was established in 3T3 fibroblasts and RAW macrophages and successfully 
maintained over 30 days, with comparable reactivation efficiencies achieved by infection with 1 
and 5 pfu/cell of Ll.50 viruses in the respective cell lines. NSO cells had a very low reactivation 
efficiency thus FACS sorting was utilized to generate enriched latently infected populations. 
These reactivation efficiencies of the Ll.50 viruses in these three cell lines are summarized in 
Table 5. 
Table 5 
Reactivation efficiencies of 3 T3 fibroblasts, RAW macrophages and NSO B cells infected with 
Ll.50 viruses at 1, 5 and 10 m.oj for the respective cell lines. 
Cell Type Virus Reactivation 
Efficiency (%) 
3T3 Ll.50luc(BAC+ ) I 47.4 +/-9.3 
Ll.50lucgMGFP(BAC-) 37.6+/-6 
RAW Ll.50luc(BAC+) 58.54+/- 7.82 
Ll.50lucgMGFP(BAC-) 51.53 +/- 1.07 
NSO Ll.50luc(BAC+) 2.0 
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DISCUSSION 
In long-term experiments exploring latency, it is important to be able to visually screen cultures 
for lytic infection. A GFP based repOlter system in which lytically and latently infected cultures 
have distinct fluorescence patterns is an ideal prelude to more sensitive assays. The 
Ll.50IucgMGFP(BAC-) virus proved superior to Ll.50luc(BAC+) in this respect, as both latently 
and lytically infected cultures may exhibit green fluorescence in the latter case (Figure 10). GFP 
expression also provided an amenable means to measure reactivation efficiency, and thus 
indirectly assess the proportion of latently infected cells in culture. With approximately 40-60% 
of 3T3 fibroblasts and RAW macrophages latently infected at I and 5 pfu/cell of Ll.50 virus in the 
respective cell lines (Figures 16 & 21), a sufficient proportion of cells are latently infected to 
yield biological material for assays such as Real time PCR. 
While the luciferase gene was initially cloned out of frame, a Ll.50luc mutant became available at 
the conclusion of this thesis, with the in frame luciferase confirmed, showing inducibility of the 
ORF50 promoter in lytic infection, as indicated by luciferase expression (Connor, personal 
communication). Having shown that latency can be established and maintained within the 
Ll.501uc system, luciferase assay under various conditions would prove u.seful in elaborating 
existing knowledge of biochemical agents and environmental conditions regulating the ORF50 
promoter. For example, LPS appeared to effect GFP expression, even in the absence of a BAC 
associate HCMV IE promoter, indicating that it has other actions beyond stimulation of this 
promoter (Figure 20). 
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In addition, 3T3 cultures infected with D.50Iuc(BAC+) and treated with P AA without 
reactivation, showed increased green fluorescence over cultures infected with D.50Iuc(BAC+) 
alone, suggesting an action on either the HCMV-IE promoter, or some basal activation of the 
viral genome (Figure 18). Luciferase assays in the presence ofLPS or PAA could reveal if these 
agents stimulate the ORF50 promoter. 
In both 3T3 fibroblasts and RAW macrophages, the reactivation efficiency is stable over the 30 
days (Figures 18 & 22). This indicates that episomal maintenance of D.50 genomes is occurring, 
with the genome being passed on with each cell division [Husain et ai, 1999). FurthelIDore, the 
ability to reactivate the GFP expressing D.50 mutants on donation of ORF50 by WT (BAC-) is an 
indication that the viral genome is latent in the cell [Wu et ai, 2000). 
3T3 and RAW cells had comparable maximal reactivation efficiencies with both D.SOJuc(BAC+) 
and D.SOlucgMGFP(BAC-) virus over 3 day and 30 day time courses. However, an increase was 
noted in the proportion of reactivated cells for both viruses in RAW cells from 1 to 2 days in the 
three 'day time course, suggesting that there is a lag in D.SO entry into RAW macrophages, also 
documented with WT MHV-68(Stevenson, personal communication). 
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Previous latency systems have been confounded by contaminating replication competent virus. 
In tbe S 11 cell line, 1 % of cells are productively infected, contributing abundant lytic transclipts 
[Husain et ai, 1999]. In this latency system, no exponential increase in green fluorescence was 
seen over 30 days in un-reactivated cultures, indicating the absence of contaminating lytic virus. 
RAW macrophages infected with ~50lucgMGFP(BAC-) did show a mild increase in green 
fluorescence in un-reactivated cultures in the first 15 days of infection (Figure 22). The 
~50IucgMGFP(BAC-) virus has a high particle to pfu ratio (2.4 xlO 4 :1), and the presence of 
many defective particles may have contributed to a hostile environment for the cells, or directly 
contlibuted to auto-fluorescence. Transcliptional assays would prove useful in clalifying whether 
there is indolent productive infection. 
B cell infection is a rare event in vivo, however it is the proliferative capacity of tbis cell type 
that generates substantial reservoirs of latent virus [de Lima et ai, 2004]. Over the 14 day time 
course, the proportion of green fluorescent cells in tbe GFP positive sorted B cell population 
actually decreased from 95% down to 16% in 14 days (Figure 25). This may be due to the 
HCMV-IE promoter shutting off over time, and the fact that GFP negative sorted populations 
went from 0 to 7% green fluorescence indicates that HCMV-IE promoter activation is valiable in 
latently infected cells. The possibility that tbe decrease in green fluorescence in GFP positive 
sorted cells is due to loss of viral genomes cannot be excluded at this point [Ciufo et ai, 2001]. 
Transcliptional analyses would indicate if this were the case. Furthermore, other reactivation 
protocols can be explored for B cells. For example, TSA has been used to reactivate latent 
genomes [DeWire et ai, 2005]. 
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While the maintenance oflatency at distant time points could be confinned in 3T3 fibroblasts 
and RAW macrophages by reactivation with WT(BAC-), this reactivation protocol could not be 
applied to NSO cells given their poor infectivity (Figure 23). However, other reactivation 
protocols can be explored, such as the use of TSA. 
These preliminary latency experiments indicated that the Ll50 latency system appears to be a 
clean latency system, although transcriptional analysis is required for confilmation. 
Characterization of the transcriptional profile of the latent Ll50 genome will provide the 
groundwork for future explorations into latency. With a clean latency system at hand, the 
establishment of a latent cell line carrying latent Ll50 genomes would allow the search for novel 
latent transcripts. 
Thus, the next step was a transcriptional analysis of the Ll50 latency system. 
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CHAPTER 3 
Transcriptional Analysis ofthe MHV -68 A50 Latency System 
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INTRODUCTION 
The peR reaction is based on the exponential copying of template DNA or cDNA to produce 
quantifiable amounts of genetic material. The amount of original template is then determined by 
backward extrapolation [Higuchi et ai, 1993]. The amplification of the small amounts of RNA 
isolated in biological assays presents a highly sensitive assay for determining whether lytic 
transcripts are present, and the ability to compare the relative abundances of latent transcripts 
over the observed time course. The relative amount of each transcript corresponds to the relative 
expression of each gene tested under the given conditions. 
Real time polymerase chain reaction CRT-peR) measures gene products over the linear range of 
amplification as they accumulate, and is preferable to end point measurements which show 
greater intra-assay variability, and less sensitivity [Schmittgen et at, 2000] . The real time peR 
assay is described in Figure 26. 
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Figure 26 
A typical TaqMan probe containing a 5' dye molecule, 6-carboxyfluorescein (6-FAM) and a 3' 
quenching molecule, 6-carboxy tetramethyl rhodamine (TAMRA) with an intervening sequence 
complementary to the DNA of interest, allowing the probe to hybridize to the template between 
the 5' and 3' PCR primers. The proximity of TAMRA to 6-FAM in the molecule allows 
TAMRA to quench the fluorescence signal of the 6-FAM dye by Forster-type energy Transfer. 
During DNA replication, the 5' nuclease activity ofTaq Polymerase cleaves the probe only if the 
probe is hybridized to the target DNA, thus preventing non specific amplification, and separates 
the reporter and quencher moieties, thus allowing the reporter dye, 6-FAM to fluoresce fully. 
Accumulation of PCR products is detected by monitoring the increase in fluorescence of 6-F AM 
[Heid et ai, 1996] ; [Mackay et ai, 2002]. The fractional number of PCR cycles required to 
generate enough signal to reach a fluorescent signal threshold determined during the exponential 
phase is defined as the cycle threshold (Ct), is directly proportional to the amount of starting 
template and thus allows the direct comparison of different gene products. Adapted from 
[Ginzinger 2002]. 
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Figure 27 
A Hypothetical Amplification Plot 
The amplification plot is the plot of fluorescence signal verus PCR cycle number. The baseline 
is defined as the PCR cycles in which a signal is accumulating but is beneath the limits of 
detection of the instrument. The signal measured during these PCR cycles is used to plot the 
threshold (dotted line). The threshold is calculated as 10 times the standard deviation of the 
average signal of the baseline fluorescent signal. A fluorescent signal that is detected above the 
threshold is considered a real signal that can be used to define the threshold cycle (Ct) for a 
sample. The Ct is defined as the fractional PCR cycle number at which the fluorescence signal is 
greater than the minimal detection level. The Ct values of different samples are then used to 
calculate the relative abundance of template for each sample. Adapted from Applied Biosystems 
DNAIRNA Real-Time Quantitative PCR Bulletin. 
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In order to ascertain the reproducibility of data, individual reactions are run in triplicate, in 
addition to performing biological replicates. The use of negative template controls screens for 
non-specific signal due to template contamination or primer dimers [Nolan et ai, 2006]. Absolute 
quantification of RT-PCR generated data is enabled by the parallel amplification of known 
concentrations of target DNA at a range of serial dilutions falling within the exponential phase of 
the amplification reaction, to generate a standard curve [Rutledge et ai, 2003] ; [Larionov et ai, 
2005]. Use of housekeeping genes as an internal control enables normalization of data, reflecting 
total RNA isolated from each preparation and taking into consideration total RNA degradation 
kinetics. 18s rRNA has been proven to be the most constant house keeping gene [Port et ai, 
2007]. 
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Selection of Transcripts for RT-PCR 
Previous in vitro and in vivo studies have identified latency associated and lytic transcripts of 
MHV-68. A review of the literature was conducted in order to select representative lytic and 
latent transcripts for application in RT-PCR assays (Table 6). 
Initial searches for latent transcripts in MHV-68 based on known latency associated genes in 
other gammaherpesviruses, revealed three distinct regions that were transcriptionally active 
during latency, in splenocytes or periteoneal macrophages derived from B cell deficient mice. 
The region encoding M2 and M3 , produced M2 transcript in both cell types. In the region 
encompassing ORFs 73 and 74, transcripts were present in latently infected peritoneal cells 
[Jacoby et ai, 2002]. 
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Table 6 
Lytic and Latency associated genes, their functions and pathogenesis deficit in MHV68. 
Provided by Efstathiou, S.E (Personal Communication). The functions of confirmed MHV -68 
genes, where known, are related to the phenotype associated with knockout mutants. Genes 
homologous to Herpes simplex virus are shown in bold, and brackets indicate that gene function 
has been determined by homology. ND indicates not determined. References are listed. 
Gene Biochemical function Pathogenesis deficit 
Ml ND Enhanced ex vivo reactivation 
M2 inhibits effects of interferon Reduced acute latency, increased long-term latency 
M3 Secreted chemokine binding protein Reduced latency amplification and intracerebral pathogenicity 
M4 ND ND 
ORF4 Complement control protein Lytic replication deficit 
ORF8 gB, cleaved virion protein, receptor binding Essential in vitro 
ORF9 Viral DNA polymerase Severe lytic replication deficit 
ORFll tegument protein Lytic replication deficit 
K3 Degrades MHC class I and TAP latency amplification deficit 
13M ND ND 
ORF21 thymidine kinase Severe lytic replication deficit 
ORF22 (glycoprotein H, virion fusion protein) Essential in vitro 
ORF27 Virion glycoprotein, cell / cell spread Lytic replication deficit 
ORF28 high glycosylated virion protein No deficit -
ORF39 Gm, heterodimer with gN Essential in vitro 
ORF47 (Gl, heterodimer with gH) ND 
ORF50 lytic cycle transcriptional activator Essential in vitro' overexpression ablates latency 
ORF51 gp150, virion protein release deficit in vitro, normal repJication in vivo 
ORF53 gN, heterodimer with gM ND 
ORF58 ND ND 
ORF65 (capsid component) ND 
ORF72 (cyclin D homolog) Reduced ex vivo reactivation 
M9 Viral capsid 
MIl bcl-2 homolog, anti-apoptotie Reduced latency amplification and pathogenicity 
ORF73 (episome maintenance) Severe latency deficit 
ORF74 chemokine receptor Reduced ex vivo reactivation 
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M2 has consistently been shown to be expressed in latency in a range of cell types in vivo arid in 
vitro [Jacoby et ai, 2002] ; [Martinez-Guzman et ai, 2003]. This makes it an ideal transcriptional 
marker for latency. ORF73 encoding LANA is also an ideal transcript to use in studying the 
course of a latent infection, given its established role in episomal maintenance [Ballestas et ai, 
1999] ; [Lan et ai, 2004]. Microarray analyses oflatently infected SII cells indicated that 
ORF73 is the most abundantly produced latent transcript, with 13 fold greater expression than 
M2. As an immediate early transcript, ORF73 is also expressed dUling lytic infection [Martinez-
Guzman et ai, 2003], while M2 is transcribed at very low levels during lytic infection. 
A third region encoding M9, homologous to the HVS ORF65 capsid protein, was identified as 
transcriptionally active during latency [Jacoby et ai, 2002]. M9, is produced only in splenocytes 
during latency, but produced abundantly during lytic infection in vitro [Martinez-Guzman et ai, 
2003]. M9 transcripts have been detected in latently infected SII B cells [Husain et ai, 1999]. It 
is unclear whether this represents low level lytic replication or a role for M9 in latency .The 
transcriptionally active region identified by RT-PCR may represent a long latent transcript 
spanning M9 rather than M9 specific transcription. 
The time course of expression of these genes has been characterized in vitro in lytic infection 
[Martinez-Guzman et ai, 2003]. Multiple transcription patterns are possible during latency in 
vivo, in different cell types, thus an in vitro latency system in which defined cell types can be co-
ordinately infected and transcription patterns analyzed would be of great utility [Simas et ai, 
1998]. 
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ORF73 peaks within 8 h.p.i while M2 peaks within 32 hours in BHK-21 cells [Martinez-
Guzman et ai, 2003]. M2 is necessary for reactivation from latency in vivo. Specifically, M2 
appears to be required for the efficient colonisation of splenic follicles [Simas et ai, 2004]. With 
a role in reactivation from latency, it is unsurprising that M2 is also expressed, albeit at very low 
levels, during lytic infection [Herskowitz et ai, 2005] . As an immediate early transcript, ORF73 
expression during lytic infection is expected [Martinez-Guzman et ai, 2003]. 
Of the potential representative lytic transcripts, M9 is the most abundant in lytically infected 
BHK-21 and 3T3 fibroblast cells making it ideal for inclusion in this analysis 
[Rochford et ai, 2001] ; [Martinez-Guzman et ai, 2003]. While it is detected at low levels at 1 
h.p.i, its transcription peaks late in infection (24 h.p.i), and is also detected during latency. For 
an unambiguous lytic marker present abundantly throughout the lytic time course, the ORF 9 
(DNA Polymerase) transcript was also selected [Ebrahimi et ai, 2003]. 
Finally, in order to characterize the ORFSO null mutant at the transcriptional level, the ORFSO 
immediate early lytic transcript was included in this study, allowing for a comparison of wild 
type to 1\.50 MHV -68 expression kinetics across a range of cell types. The 1\.50 deletion does not 
encompass the entire ORFSO transcriptional unit, thus primers have been designed to detect the 
-. 
undeleted regions of the primary transcript (Coleman, personal communication). 
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METHODS 
Viral DNA Purification and Quantification 
For RAW macrophages, 5x 104 cells/well were seeded in a 6 well plate and grown to 70% 
confluence overnight. Cells were infected with 10 pfu/cell of t.50IucgMGFP(BAC-). Cultures 
were incubated for I, 2, 4, or 6 days with 10% DMEM. For NSO B cells, infected cultures were 
sorted into GFP positive and GFP negative populations by FACS. Infected cultures were 
incubated for 7 days with 10% DMEM. To harvest DNA, cells were rinsed with PBS, and 250ul 
ofTE buffer (lOmM Tris: 50mM EDTA, pH8). 25 III of 10% SDS and IIl120mgmr i proteinase 
K were added to samples, and incubated at 37°C overnight. Samples were sonicated for 2 x I 
min to generate DNA pieces 5-6Kb in size. DNA was purified according to the Qiaquick PCR 
Purification kit (Qiagen) protocol. DNA concentration was determined using the ND 1000 UV 
Vis Spectrophotometer (Nanodrop). 
DNA samples were subjected to real time PCR with HotStar Taq (Qiagen) using TaqMan probes 
and the relevant primer sets using the Rotor Gene RG 3000 (Corbett Research). PCR products 
were quantitated alongside a standard curve of cloned template from purifie(!.plasmid dsDNA for 
each transcript, which are listed in table 7. 
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RNA Isolation 
For all cell lines used, 5x 104 cells/well were seeded in a 6 well plate and grown to 70% 
confluence overnight. Cells were infected with either I pfulcell of l'.50lucgMGFP(BAC-) or WT 
virus. Given the high particle to pfu ratio, t.5OlucgMGFP(BAC-) was also used at 10 pfulcell. 
RNA was extracted from infected cells according to the manufacturer's instructions for the RNA 
aqueous 4 PCR ™ kit (Ambion). Reagents are listed in appendix 2. Briefly, cells were washed 
with Ix PBS, and 300/-11 of lysis solution were added. Cells were scraped from the monolayer 
into solution, and collected into 1.5ml eppendorf tubes. Samples were vortexed, and an equal 
volume of 64% ethanol added. Samples were applied to filter cartridges and subjected to serial 
washes. Cartridges were placed in fresh collection tubes and eluted in 60 /-11 of hot elution 
solution. RNA concentration was determined using the ND 1000 UV Vis Spectrophotometer 
(Nanodrop). RNA samples were stored at -70°C. 
PolyA+ Selection ofmRNA from total RNA 
mRNA was selected from total RNA using the Micro PolyA Purist ™ kit (Ambion). 5/-Lg of 
RNA was diluted in RNA storage solution (Ambion) to a total volume .. of 250/-L1. An equal 
volume of 2X binding solution was added. The RNA sample was applied to oligo-dT Cellulose 
resin (Ambion), and mixed thoroughly. Incubation of the mixture for 5min at 75°C was followed 
by gentle agitation on a rotator for Ih to ensure RNA binding to resin. 
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Resin was pelleted by centrifugation at 4,000xg in a pi co microfuge (Heraeus) for 3 min at RT, 
and applied to a spin column, with serial washes performed to remove non-specifically bound 
material and ribosomal RNA from the resin. 
PolyA +RNA was recovered in a fresh collection tube by elution with 200Jll elution solution 
(Ambion) at 75°C, and centrifuged at 5000g x2 min in a pico microfuge (Heraeus) PolyA+ RNA 
was precipitated with 20 Jll of 5M Ammonium acetate, 1 Jll of 5mglml glycogen, and 550 Jll of 
100% ethanol. RNA samples were stored at -70°C. 
DNAse treatment of RNA 
RNA was subjected to Turbo DNAse (Ambion) treatment to eliminate any contaminating DNA 
in samples prior to reverse transcription to generate eDNA. 4 Jll of 10xTurbo DNA buffer and 
0.5 Jll of 2U/JlITurbo DNAse was applied to 40 Jl1 RNA samples and 40 Jll mRNA samples. 
Samples were incubated for 30min at 37°C. An additional 0.5Jll of Turbo DNAse was added to 
samples with a further 30min incubation. 12.5Jll of DNAse Inactivation Agent (Ambion) was 
added and incubated for 2min with mixing, followed by centrifugation at 1 O,OOOxg for 1.5min to 
precipitate the inactivation agent. RNA samples were stored at -70°C. 
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Reverse Transcription of RNA 
RNA samples were reverse transcribed to generate cDNA template to be used for RT-PCR, using 
the MessageSensor RT kit™ (Ambion). Duplicate preparations of O.S J.lg RNA template in 4J.ll 
aliquots, 3.S J.ll of primer supermix containing equal volumes of all 7 primers at 10J.lM 
each(Table 6), and 4.SJ.ll of water were made, and denatured at 6S0C for Smin in a Thermal 
Cycler (Bio-Rad). A minus template control was prepared by substituting 4J.ll of nuclease free 
water for the RNA template. 
8J.ll of an RT master mix containing 2J.ll lOx RT-PCR buffer, 4J.ll dNTPmix (containing 2.SmM 
each of dATP,dTTP, dGTP and dCTP), 2J.ll of 10UIul RNAse inhibitor(Ambion) and 2J.ll ofM-
MLVRT was then added to each RT sample. 4ul of the 2.5mM d.NTP mix and 4ul water were 
applied to the corresponding minus RT controls. Primer extension occurred at SO°C for 60min, 
and M-MLVRT denaturation at 9S °Cfor 10 min, to prevent illegitimate reverse transcription 
duringPCR. 
Real Time peR on eDNA template 
A supermix containing the appropriate primer set and TaqMan Probe, 2Sm.M MgCh to the final 
concentrations shown in table 8 was prepared. Reactions were optimized by Dr Coleman, with 
the appropriate combination of 2.SmM dNTP mix, lOX PCR buffer (Qiagen), 0.4 Ulul Taq 
Polymerase (Qiagen) and nuclease free water added for each primer set. 
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12111 of supermix was dispensed to sample tubes, and 8111 of cDNA template added to a final 
volume of 20111. Standards were prepared by adding 48111 of supermix to 28 III of H20 and adding 
4111 of DNA to make 3 x 20111 aliquots for triplicate reactions. Standards were made by serial 
dilution of DNA plastnids listed in Figure 7, in salmon sperm DNA to generate standards ranging 
from 10° to 1010 copies/ill. Denaturation was performed at 95°C x 15min. Cycling parameters 
were 95°C x 15sec, and 60°C x 60sec for 45 cycles. 
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Table 7 
Primer sets used for RNA and DNA Quantification by RT - peR 
(F) =(S) and denotes the forward/sense primer reading in the 5'to 3' direction 
(R)= (A) and denotes the reverse/antisense primer reading in the 3' to 5' direction 
TM denotes the Taqman Probe, an oligomer containing a sequence complementary to the DNA 
in question and containing the 5' dye 6-carboxyfluorescein(6-FAM) and the quenching molecule 
6-carboxy tetrarnethyl rhodamine (TAMRA) 
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MHV-68 Standard Plasmid Primer ffaqman Probe Sequence MHV-68 TaqmanMHV-6~ 
promoter sequence sequence 
region coordinates coordinates 
ORF9 PEcoRV-H in pSP73 (A) (F) 20695- 20844-20825 
promoter 5'CTgATTTgATggCAggATgTAgTTC 20716 
(S) (R) 20890-
5' -ggTgCTgACTgATggACA 20825 
TM5' 
6F AM-CTCCTggCAgCgTCgAgCAA-TMR 
M9 p.BAMHI-F in pUCl3 (F) 5' CTAAAgCTgTTCCCgTCAgACAT (F) 94053- 94096-94122 
(R) 5'gTCCCTTCCTCTTCTggAgCAT 94075 
TM5' (R) 94225-
6FAM-AgCACAAAACCCAgTCCAgACTTgTCA-TMR 94204 
M2 p.HIND III E in (R.) (S) 4166- 42 19-4 189 
pUCI3 5' ATCT ATgAAACTgCT AACAgTgAACC 4188 
(S) (R) 4252-
5'gTCAgTCgAgCCAgAgTCCAAC 4228 
TM5' 
6FAM-
CCAgCCAATCTCTACgAggTCCTT AATgA-TMR 
Ort73 BAMG in p.ACYCI84 (F) (F) 104047- 104079-104104 
5'TgTggATggCTgCTCgg 104063 
(A) 104173-
(A) 104153 
5'ggTTgTCTTggCCTACTgTgAA 
TM5' 
6FAM-
5'CTgTAggggggCTCTggT AAgggAAAA- TMR 
ORF50 p.REVTRE.ORF50 (F) (F) 66779- 67698-67670 
5' CCCCTTCAgCCgATAAggAC 66795, 
(R.) 67661-67664 
5' CAgggTgCTgTAggAAgCAT (R) 67775-
TMS' 67756 
6FAM-AACTggCTCAAgTAgACCTgCTTCgATCC-
BBQ 
Murine p.GEMEASY-T (F)Cgg CT A CCA CAT CCA Agg AA Radonic et ai, 
18S with an insert 2004 
corresponding to the (R) gCTggAA TTACCgCggCT 
peR product 
TM5' 
6FAM-CgCAAATTACCCACTCCCgACCC 
117 
Table 8 Primer, TaqMan Probe and MgCI, Concentrations used in Real Time RT-PCR 
Primer Set Reagents Final Concentration nM 
ORF9 F primer 900nM 
R primer SOnM 
TaqMan Probe SOnM 
MgCI, 4.SmM 
M2 F primer SOOnM 
R primer SOOnM 
TaqMan Probe SOnM 
MgCl, S.SmM 
M9 F primer SOnM 
Rprimer 900nM 
TaqMan Probe SOnM 
MgCl, 3.5mM 
ORF73 F primer SOnM 
A primer 900nM 
TaqMan Probe SOnM 
MgCI, 3.SmM 
ORF SO F primer 900nM 
Rprimer 300nM 
-
TaqMan Probe SOnM 
MgCl, 3.SmM 
Murine l8S ribosomal RNA F primer SOnM 
Rprimer SOnM 
TaqMan Probe 2SnM 
MgCl, 4.5mM 
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RESULTS 
Latency experiments showed that the two ~50 viruses had comparable reactivation efficiencies 
in 3T3 and macrophage cells, but that ~501ucgMGFP(BAC-) was superior to ~50luc(BAC+) in 
distinguishing between latent and lytic infection (Chapter 2). To characterize ~50 at the 
transcriptional level, clone 11 cells were infected with ~501ucgMGFP(BAC-), and compared to 
WT as shown in Figure 28. 
Ribosomal RNA presents a reliable internal standard as it is constitutively expressed at similar 
levels in different cell types, and levels in cultured cells do not vary significantly in response to 
viral transformation or altered environmental conditions [Goidin et ai, 2001]. Normalization of 
each transcript to 18S rRNA transcript at each time point enabled correction for variation in total 
RNA yield and in the cDNA yield from the reverse transcription step. 
In Clone 11 cells infected with WT (BAC+), the total RNA yield was relatively stable over 24 
hours, with 18S transcript number starting to decrease slightly secondary to cell death, as seen in 
figure 10. The lytic transcripts M9, and to a lesser extent ORF50 and ORF9, were highly 
expressed throughout the 24 hour time course. The latent transcripts M2 and ORF73 were 
expressed at low levels initially, but increased by 2 logs by 24 h.pj potentially reflecting the 
transcriptional profile ofa subset of infected cells destined for latent infection (Figure 128). 
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Figure 28 
Clone 11 cells seeded at 5 x 10 4 cells/well in the presence of 1.0 mglml of doxycycline, were 
infected with 1 pfu/cell of either WT(BAC+) or L'.50lucgMGFP(BAC-), were harvested at 5,12 
and 24 h.p.i for RNA. 0.511gofRNA was reverse transcribed, and the RT product subjected to 
Real time PCR against a primer specific standard curve. The transcript copy numbers for each 
sample was deducted from minus RT controls, and normalized to 18S transcript numbers at the 
corresponding time point. The transcriptional profile oflatent (M2, ORF73) and lytic (M9, ORF9, 
ORF50) transcripts are compared. 
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Overall, the transcriptional profile of L\.50lucgMGFP(BAC-) closely resembled WT (BAC+)over 
the 24 hours, with respect to the relative transcript peaks. In conjunction with single step growth 
curves (Figure 6), this result indicated that L\.50IucgMGFP(BAC-) is fully complemented in the 
clone 11 cell line. 
Transcription profiles were compared in 3T3 fibroblasts and RAW macrophages following 
infection with L\.50IucgMGFP(BAC-). Initial experiments conducted at 5 pfu/cell with 
L\.50lucgMGFP(BAC-) virus in RAW macrophages gave very low Real Time PCR readouts, 
thus experiments were conducted at 10 pfu/cell of L\.50lucgMGFP(BAC-) which resulted in 
comparable transcript yields to those attained in 3T3 cells ( Figures 29 & 30). 
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Figure 29 
3T3 fibroblasts were infected with 1 pfu/cell of either a) WT(BAC+) or b) il50IucgMGFP(BAC-), 
and harvested at 5,12,24,48, and 72 h.p.i for RNA. O.5J.lg of RNA was reverse transcribed, and 
the RT product subjected to Real time PCR against a primer specific standard curve. The 
transcript copy numbers for each sample was deducted from minus RT controls, and normalized 
to 18S transcript numbers at the corresponding time point. The transcriptional profile of latent 
(M2, ORF73) and lytic (M9, ORF9, ORF50) transclipts are compared. 
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With WT (BAC+) MHV-68 infection oOT3 fibroblasts, there was an increase in all viral 
transcripts over the first 24 hours, with the latent transcripts M2 and ORF73 expressed at the 
lowest levels, M9 expressed up to 3 logs higher, and ORFSO and ORF9 again showing 
intermediate levels of expression. 
With I\.SOlucgMGFP(BAC-) infection oOT3 fibroblasts over the 72 hour time course, there was 
an increase in the number of cells as inferred from the increase in 18S transcript yield (Figure 
29b. Except for ORFSO, the extent of latent transcript expression is high in I\.SOlucgMGFP(BAC-) 
infected 3T3 cells in proportion to the lytic transcripts at each time point. Given the dual 
objectives of remaining undetected by the immune system while maintaining the viral genome in 
latently infected cells, it is ideal for latent transcripts to be expressed at low absolute levels. 
In contrast to data obtained following infection of3T3 cells where viral transcripts peaked within 
24 hours, there was an overall increase in both latent and lytic transcripts over the 48 hour time 
course in RAW macrophage infection (Figure 30). This is consistent with the lag in I\.SO entry 
into RAW cells noted by flow cytometric analyis (Figure 21). 
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Figure 30 
RAW macrophages were infected with either a) 1 pfu/cell ofWT(BAC+) orb) 10 pfu/cell 
~50IucgMGFP(BACc) viruses pre-incubated with anti gp150 antibody, and harvested at 5, 12, 
24, 48, and h.pj for RNA. 0.5 ~gofRNA was reverse transcribed, and the RT product subjected 
to Real time PCR against a primer specific standard curve. The transcript copy numbers for each 
sample was deducted from minus RT controls, and normalized to 18S transcript numbers at the 
corresponding time point. The transcriptional profile oflatent (M2, ORF73) and lytic(M9, ORF9, 
ORF50) transcripts are compared. 
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M2 expression was lower than ORF73 expression in the first 24 hours ofRA W 
L\.50IucgMGFP(BAC-) infection, similar to the overall trend with 3T3 infection, but surpassed 
ORF73 during the 24c48 hour time point. The lytic transcripts M9 and ORF9 were 5-6 logs 
higher in the WT scenario than L\.50IucgMGFP(BAC-) over the 48 hour time course. The peak 
transcript copy numbers and the times at which they occur for latent infection with 
L\.50IucgMGFP(BAC-) in both cell lines are listed in table 9. 
Table 9 
Peak viral transcript copy numbers and time of peak (h.p.i) are shown for 
3T3 fibroblasts and RAW macrophages latently infected with L\.50IucgMGFP(BAC-) at 1 and 10 
pfu/cell in the respective cell lines. 
CELL 
LINE TRANSCRIPT 
ORF73 M2 M9 ORF9 ORF50 
Peak time peak Time peak time peak time Peak time 
3T3 2.6 5 2.0 12 2.1 12 1.2 24 3.8 24 
RAW 2.3 24 3.7 24 2.6 24 0.9 24 2.0 24 
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Reactivation of latent genomes showed that the viral genome was being maintained over the 
course of 30 days (Figures 18 & 22). In RAW macrophages, a slight increase in fluorescence had 
been noted over the first 15 days oflatent infection. To dete=ine whether this was increase was 
due to indolent lytic infection, and to dete=ine the transcriptional profile in long te= 
maintenance of latency, the transcriptional profile in the 1'.50 latency system over the course of 
30 days was examined in both 3 T3 fibroblasts and RAW macrophages as shown in figures 31 
and 32 respectively. 
These analyses focused on the latent transcriptsM2 and ORF73, and the lytic transcript ORF9, 
which showed a more distinct pattern of transcription between latent and lytic infection than the 
lytic transcripts M9 or ORF50 (Figures 28-30), and was thus anticipated to provide a more 
rigorous transcriptional marker oflatent or lytic infection. 
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Figure 31 
3T3 fibroblasts seeded at 5 x 104 cells/well in a six well plate were infected with 5 pfulcell of 
!l.50IucgMGFP(BAC-), and harvested at 1, 5,10,15,20,25 and 30 days post infection, for RNA. 
Cells were passaged every four days from the day of infection, and re-suspended at 5 x 104 
pfulwell. 0.5llgofRNA was reverse transcribed, and the RT product subjected to Real time PCR 
against a primer specific standard curve. The transcript copy numbers for each sample was 
deducted from minus RT controls, and normalized to 18S transcript numbers at the 
corresponding time point. The transcriptional profile oflatent (M2, ORF73) and lytic (ORF9) 
transcripts are compared. 
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Figure 32 
RAW macrophages seeded at 5 x 104 cells/well in a six well plate were infected with 
10 pfu/cell of ~50IucgMGFP(BAC-), and harvested at I, 5, 10, 15,20,25 and 30 days post 
infection, for RNA. Cells were passaged every four days from the day of infection, and re-
suspended at 5 x 104 pfu/well. 0.5f!gofRNA was reverse transcribed, and the RT product 
subjected to Real time PCR against a primer specific standard curve. The transcript copy 
numbers for each sample was deducted from minus RT controls, and normalized to 18S 
transcript numbers at the corresponding time point. The transcriptional profile of latent (M2, 
ORF73) and lytic (ORF9) transcripts are compared. 
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In 3T3 cells over the 30 day time course, the cellular and latent transcripts are relatively stable. 
This suggests that the viral genome is passed on with each cell division, consistent with the 
relatively stable expression of ORF73 and its role in episomal maintenance. The mild 
fluctuations in transcript number likely represent viral genome responses to changing 
environmental conditions with each passage performed every four days. ORF9 has negligible 
expression over the 30 day time course (Figure 33). If any background level oflytic virus was 
present, over the 30 day time course, ORF9 expression would increase significantly. 
A comparable transcriptional profile is seen in RAW macrophages over the 30 days, although 
M2 expression is higher in RAW macrophages (Figure 32). This may reflect a more efficient 
regulation of latent transcripts in RAW macrophages which are a site if latent infection in vivo 
unlike fibroblasts. ORF9 expression was variably low, with no exponential increase noted over 
the time course, indicating the absence of even an indolent, lytic infection. These analyses 
confirm at the transcriptional level that the L'l.50 latency system is devoid of contaminating WT 
replication, and gives an insight into the latent transcriptional profile. 
Total RNA and mRNA were isolated £i·om L'l.50lucgMGFP(BAC-) infected RAW cultures, to 
. compare the viral transcript yields between these two sources.Overall, . .similar viral transcript 
yields were obtained between the two isolation methods, indicating that the intensive protocol 
involved isolating mRNA did not improve transcript yield, and that using total RNA as template 
was appropriate (Figure 33). 
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Figure 33 
RAW macrophages were infected with 10 pfulcell .6.50IucgMGFP(BAC-) viruses pre-incubated 
with antigp 150 antibody, and harvested at 1,2,4, and 6 days post infection for RNA. 0.5 J.lgof 
RNA was reverse transcribed, and the RT product subjected to Real time PCR against a primer 
specific standard curve. The transcript copy numbers for each sample was deducted from minus 
RT controls, and normalized to 18S transcript numbers at the corresponding time point. The 
transcriptional profile oflatent (M2, ORF73) and lytic (M9, ORF9, ORF50) transcripts are 
compared. 
134 
Total RNA 
10 
9 
8 
i 7 
~ 6 _ ORF9 
11 5 
~M2 
i 0 ORF73 • 0 0 4 _ 185 3 . ,~ 
~ 
2 
1 
0-
• 0 
0 
1 2 4 6 
d;ays post infoction 
mRNA 
8 
~ 
7 
.. 
-
6 
i 
I 5 _ ORF9 ~M2 11 4 
I - ORF73 3 _ 185 """"'" 
2 
~ 
--
1 
0 
1 2 4 6 
days post infoction 
135 
In order to determine the stability of DNA during the latent time course, DNA was isolated from 
t.50lucgMGFP(BAC-) and subjected to Real Time PCR (Figure 34). Overall, the DNA of 
ORF73, M2 and ORF9 were relatively stable, with a drop in transcript number seen at 2-4 days 
in all the viral transcripts tested. This decrease was not due to passaging as for this brief 
experiment, cells were not passaged, but were fed fresh 10% DMEM at day 4. 
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Figure 34 
RAW macrophages were infected with 10 pfu/cell ~50IucgMGFP(BAC-) virus pre-incubated 
with antigpl50 antibody. At 4 d.p.i, media was removed from culture, and replaced with fresh 
10% DMEM. Cultures were harvested at 1,2,4, and 6 days post infection. O.5J.lgofDNA was 
diluted in 200ul nuclease free water, and SuI aliquots in triplicate subjected to Real time PCR 
against a primer specific standard curve. The genome copy number for each sample was 
deducted from minus RT controls, and normalized to the genome copy number at the 
corresponding time point. The genome copy numbers for latent (M2, ORF73) and lytic(M9, 
ORF9, ORF50) genes are compared. 
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Having established the transcriptional profile of the Ll50 latency system in comparison to lytic 
infection in the permissive 3T3 cell line, and RAW macrophages, a site of latent infection in vivo, 
the next step was to determine the transcriptional profile in B cells, the primary site oflatent 
infection in vivo. 
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Figure 35 
NSO cells were infected with a) ~gp150 at 3 m.oj, b) WT (BAC+) at 7 m.oj, and c) 
~50IucgMGFP(BAC-) at 20 m.oj. and harvested at 12, 24 and 72 h.pj, for RNA. 0.5J.lgofRNA 
was reverse transcribed, and the RT product subjected to Real time PCR against a primer specific 
standard curve. The transcript copy numbers for each sample was deducted from minus RT 
controls, and normalized to ISS transcript numbers at the corresponding time point. The 
transcriptional profile oflatent (M2, ORF73) and lytic (M9, ORF9, ORF50) transcripts are 
compared. 
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Over the 72 hour time course, similar total RNA yields were attained at each time point, with 
similar 18S rRNA transcript numbers for the three viral cultures. The gp 1 SO infected isolates had 
the highest of all viral transcripts, consistent with the enhanced infectivity of this mutant in NSO 
cells (Figure 35a). Lytic transcripts were characteristically higher than latent transcripts, 
although the difference was lower than in RAW or 3T3 cells. 
WT viral transcripts bore the same overall relationship to each other as L\.gp I SO viral transcripts, 
although there was a lag in infection in WT virus reflecting the non permissive nature of B cells. 
ORF9 alone decreased over the 72 hour time course in WT infection, contrary to the 3 log 
increase in L'lgp 1 SO (Figure 35b). 
All viral transcripts were lower at the early 12 hour time point in L'l50lucgMGFP(BAC-) infected 
cultures, than either the L'lgp150 (BAC+) or WT (BAC+) infected cultures reflecting the 
partiCUlarly poor infectivity ofNSO cells with L'l50lucgMGFP(BAC-). However, a very different 
trajectory occurred with L'l50IucgMGFP(BAC-), with all lytic transcripts decreasing within the 
first 24 hours, as occurred with L'l50IucgMGFP(BAC-) infection in 3T3cells, but then rising 
again from 42 -72 hours, possibly reflecting increasing numbers of cells newly infected by virus 
that had previously not entered cells due to poor infectivity (Figure 35c). ORF73 also increases 
slightly from 24-72 h.pj while M2 decreases slightly. The low latent transcript yield compared 
to lytic transcripts in L'l50lucgMGFP(BAC-) infected NSO cells may reflect a greater efficiency in 
latent transcript processing in B cells, such that lower levels of the latent transcripts can achieve 
the desired results of episomal maintenance and immune evasion. 
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The low proportion of latently infected cells in NSO cultures limits analysis. In order to generate 
enriched populations oflatently infected cells, NSO cells infected with Ll.50Iuc(BAC+) were 
sorted into GFP positive versus GFP negative populations. The sorting process yields only Ixl 03 
GFP positive cells, however B cells proliferate in culture ( Figure 24). At 7 days post sorting, the 
number of cells in culture had amplified to approximately I x 10 5 cells/well, and were harvested 
at this time point in order to yield adequate amounts of RNA and DNA to assay (Figure 36). 
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Figure 36 
NSO cells were infected with Li.50lucgMGFP(BAC-) at 20 m.oj, with FACS sorting I day post 
infection, into GFP+ and GFP- populations. Cultures were harvested 7 days following sorting, 
yielding 
a) 0.5flg of RNA which was reverse transcribed, and the RT product diluted in 200fll nuclease 
free water, with 8 ul aliquots in triplicate subjected to Real time PCR against a standard curve. 
b) 0.5flg of DNA which was diluted in 200fll nuclease free water, and 8fll aliquots in triplicate 
subjected to Real time PCR against a primer specific standard curve. The transcript copy 
numbers for each sample was deducted from minus RT controls, and normalized to 18S 
transcript numbers at the corresponding time point. The transcriptional profile oflatent (M2, 
ORF73) and lytic (ORF9) h'anscripts are compared. 
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Viral transcripts were expressed at low levels in GFP+ sorted cells, consistent with the latency 
objective of immune evasion. No viral transcripts were detected in the infected but unsorted 
populations at either I or 7 days, or the GFP negative sorted population, possibly due to the very 
low concentration of latently infected cells (Figure 36a). The RNA transcript yield was compared 
to DNA yield (Figure 36b). ORF73 DNA was detected in the GFP+ population, but was absent 
in the GFP- population, and the infected but unsorted populations. An absence ofORF73 
suggests a failure of episomal maintenance, which raises the question whether DNA detected for 
the ORF 9 and M2 transcripts is due to extra cellular viral DNA or viral episomal DNA. This 
could be clarified with a gardella assay for episomal DNA [Gardella et ai, 1984]. 
In summary, RT-PCR analysis of fibroblast, macrophage and B cell lines confirm at the 
transcriptional level that the ,'1.50 latency system is a tractable latency system which can be 
manipulated for the purposes of establishing and maintaining latency, but can also be reactivated 
to lytic replication. Furthermore, this work shows that it is a clean latency system devoid of 
contaminating WT virus. The immediate challenge is to optimize B cell infection and 
maintenance oflatency, with the goal of generating a clonal latent B cell line, which can then be 
applied to the search for novel latent transcripts. 
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DISCUSSION 
The transcriptional profile of Ll.50 MHV -68 virus in latency was characterized and compared to 
lytic gene expression, for a representative subset of lytic and latent transcripts. In keeping with 
single step growth curves, these studies have confirmed at a transcriptional level that the Ll.50 
mutant is fully complemented by ORF50 expressed from the clone 11 cell line, with no 
secondary mutations that impact growth (Figure 6 & 30). 
The lytic transcriptional profile on infection with WT (BAC+) in permissive 3T3 fibroblasts was 
analysed, showing that the lytic transcripts M9 and ORF9 peaked at 24 hpi, the latent transcript 
M2 peaked after 24 hpi, and ORF73 stayed within a similar range from 5 h.p.i onwards (Figure 
29). This resembles the expression time course seen in previous in vitro studies in BHK-21 cells, 
where ORF9 transcript levels peaked at 24 h.p.i, M2 peaked by 32 h.p.i, and ORF73 peaked 
within 8 hours [Martinez-Guzman et ai, 2003]. ORF50 transcript levels peaked at 8 h in BHK-21 
studies whereas here it peaked at 24 hpi (Figure 29). The reason for a difference in ORF50 
expression profiles is unclear. 
In RAW macrophages all viral transcripts were still rising at the conclusion. of the 48 hour time 
point, while cellular transcripts remained stable. Thus the observation that virus seems to be slow 
to enter RAW macrophages, even with gp 150 antibody potentiation, was confinned at the 
transcriptional level (Figures 21 & 30). 
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While the transcriptional profile during latent infection during the first 14 days oflatency 
establishment has been described in vivo, the expression profile during the early phase of latency 
establishment with MHV-68 has not previously been described, and in this study was facilitated 
by infection of cells with an ORF50 replication defective mutant. In vivo studies of splenic cells 
showed by real time PCR the presence of ORF50 at very low levels, but absence ofM2 or 
ORF73 in macrophages, while B cells expressed both M2 and ORF73 but no ORF50, at 14 d.p.i 
[Marques et at, 2003]. Here, following .6.50lucgMGFP(BAC-) infection of3T3 fibroblasts, M9 
transcription peaked at 12 h.p.i, but was undetectable by 60h (Figure 29). ORF9 transcription 
peaked by 24 h and was undetectable by 48 hpi. ORF50 transcription peaked by 24 hpi, and in 
the absence of the auto activation seen in lytic infection, reached very low levels by 72 hpi. The 
amount of ORF50 present never reached zero however, which may be due to residual non 
degraded mRNA, or may reflect a constitutive basal level of ORF50 promoter activation. 
For the latency transcripts, ORF73 transcription peaked within 5 hours, dropping to very low 
levels after 48 hours. M2 transcription peaked by 12 hours, and dropped down to undetectable 
levels by 60 h.p.i (Figure 29). Transcripts may appear artificially low between 48 and 72 h.p.i 
given that they are normalized against 18S, and 18S expression increased substantially between 
48 and 72 hours. On inspection of the non-normalized data, M2 transcript levels were low at 72 
h.p.i, however ORF73 transcript levels were at their highest at 72 h.p.i. 
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The relationship between transcripts was similar for RAW macrophages to that seen in 3T3 
fibroblasts. The major difference was that in RAW macrophages, at 48 h.p.i, all viral transcripts 
were still increasing in amounts, following infection with both the WT and "'50IucgMGFP(BAC-
)viruses( Figure 30); This supports at the transcriptional level, the observation that MHV -68 is 
slow to infect RAW macrophages, even in the presence of potentiating antigp150 antibody 
(Figure 21). 
At the early time points, the relationships between transcripts was complicated, with 
transcription levels adjusting to the latent program, with an interplay between viral, cellular and 
environmental factors to reach steady state levels. The long term latency experiments over 30 
days clarified the relationship between transcripts, with latent and lytic transcripts expressed at 
similar levels in both 3T3 fibroblasts and RAW macrophages. Of note, M2 was more highly 
expressed in RAW macrophages, than 3T3 fibroblasts, relative to ORF73 (Figures 31 & 32). M2 
has anti-apoptotic properties, facilitating differentiation oflatently infected germinal centre B 
cells into memory B cells [Simas et aI, 2004]. It also modulates Vav B cell signalling protein 
activity, subverting T/CD8+ lymphocytes elimination ofB cells carrying the MHV-68 genome in 
vivo. M2 contains a CD8 epitope, thus it is thought that M2 expression results in T cell 
recognition and elimination [Rodrigues et aI, 2006]. The higher M2 expression in RAW 
macrophages may relate to a higher efficiency in its regulation in macrophages which are 
immune cells in which latency naturally occurs. 
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The role played by ORF73 in episomal maintenance has been well defined [Ballestas et al, 
1999] ; [Fowler et al, 2003]. Importantly, these 30 day assays provided evidence at the 
transcriptional level, that the viral genome was being maintained, given the stable levels of 
ORF73 in 3T3 fibroblasts and RAW macrophages over the time course ( Figures 31 and 32). 
Furthermore, a 6 day time course in RAW cells infected with t.50IucgMGFP(BAC-) showed 
DNA to be stable over time (Figure 34). The transcriptional picture reflects the stable 
reactivation efficiencies achieved in both cell lines. Furthermore, the 30 day profile proves 
conclusively at the transcriptional level, the absence of contaminating lytic virus, with negligible 
ORF9 transcription (Figures 18 and 22). The small increase in fluorescence seen in figure 22 is 
thus not due to indolent lytic replication, but likely represents a higher level of auto-fluorescence. 
The distinct transcriptional profiles seen in latent versus lytic transcription in 3T3 fibroblasts and 
RAW macrophages corroborates the GFP expression phenotypes seen in latency experiments 
(Chapter 2). On a practical level, this is useful knowledge for the design of future experiments, 
where a visual screen oflatently infected cultures can indicate the presence ofWT reversion, in 
individual wells, without employing the time consuming assay of real time PCR. Transcriptional 
assays also serve as a prelude to sensitive assays for identifYing novel latent transcripts in a 
latency system rigorously screened for lytic contamination. 
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FUTURE DIRECTIONS 
While RAW macrophages do harbour latent MHV -68, B cells are the site oflong tenn latency in 
vivo. It will thus be of importance to adequately explore the 1'.50 latency system in a B cell line. 
Characterization of the 1'.50 latency system in the NSO B cell line is hampered by inefficient viral 
infection. While enriched populations oflatently infected cells can be generated by FACS sorting, 
this still produces small numbers of infected cells. 
M7 encodes the viral glycoprotein gp ISO. 1'.M7 paradoxically has an enhanced ability to infect 
B cells, which express low levels of GAGs, to which gpl50 binds [de Lima et ai, 2004]. In this 
study, 1'.M7 was shown to have a reactivation efficiency of 18% following super-infection with 
WT virus, compared to 2% reactivation efficiency in cultures latently infected with 
1'.50Iuc(BAC+). Construction of a double mutant containing both 1'.M7 and 1'.50 mutations would 
be ideal as the enhanced infectivity of 1'.M7 coupled with the latency phenotype of the 1'.50 
mutant would allow coordinate latent infection of a significant proportion of B cells. Given the 
adjacent locations of these two genes, such a mutant could be made with a deletion spanning that 
region. The pathogenesis deficit of the 1'.M7 mutant is decreased virion relea.se from infected 
cells, and does not interfere with latency [de Lima et at, 2004]. With a means to co-ordinately 
infect large numbers ofB cells in culture, the transcriptional profile in the B cell line could be 
explored with the success seen in 3T3 fibroblasts and RAW macrophages. The ideal conclusion 
would be to establish a clonal B cell line stably carrying the latent 1'.50 mutant genome. 
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With the ability to latently infect and then reactivate the latent !'-50 mutant genome, gene 
expression profiles in latent versus lytic infection could be examined. For example, it is now 
known that the t-RNA's encoded by MHV-68 each contain an miRNA [Pfeffer et at, 2005]. In 
another example, ORF73 is known to produce both a spliced and unsliced transcript [Coleman et 
at, 2005]. The expression profiles of these gene products during the establishment and 
maintenance oflatency, in comparison to lytic infection, can be examined with in such a system. 
Finally, the !'-50 latency system could be applied to the search for novel latent transcripts. A 
powerful technique for this purpose is subtractive hybridization, which enables comparison of 
two mRNA populations, by obtaining clones of genes expressed in one population but not the 
other, in this case latency associated genes, with selective amplification. 
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APPENDIX I 
Reagents for Latency Experiments 
Tissue Culture 
Dulbecco's Modified Eagle's Medium (DMEM) 
Fetal Calf Serum (FCS) 
P AA Cell Culture Company 
Gibco 
GMEM -Glasgow Minimum Essential Medium 
Doxycycline 
P AA Cell Culture Company 
Clontech 
Hygromycin 
G418 
Puromycin 
Carboxymethylcellulose (CMC) 
Phosphonoacetic acid (P AA) 
Lipopolysaccharide (LPS) 
Flow Cytometry 
Bovine Serum Albumin (BSA) 
Luciferase Assay 
Gly gly buffer 
Sml 
l.Sml 
2.22ml 
91.3ml 
Lysis buffer 
2Sml 
1ml 
12Sfll 
Luciferase Assay Buffer 
21ml 
4.2ml 
280fll 
280fll 
Luciferin Mix 
1ml Luciferin 
4ml gly-gly buffer 
SOflllM DTT 
Clontech 
Clontech 
Clontech 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Invitrogen 
O.S M glycylglycine Ph7.8 
1M MgS04 
180mMEDTA 
water 
gly-gly buffer 
2S% Triton-X-100 
100mMDTT 
gly-gly buffer 
KP04 buffer 
100m.MDTT 
2S0m.MATP 
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APPENDIX II 
Reagents Real Time PCR 
RNA Aqueous 4 PCR 
lOX DNase I Buffer (lOOmM Tris/25mM MgCI/lmM CaCI 
2 units/~L DNase I (RNase-free) 
I mL 5M Ammonium Acetate -20°C 
Water for 64% Ethanol 
DNase Inactivation Reagent 
Lysis/Binding Solution 
(4 M guanidinium isothiocyanate, 100 mM Tris·CI, pH 7.0) 
Wash Solution I 
Wash Solution 2/3 
Micro polyA+ Purist 
Lysis Solution 
(4 M guanidinium isothiocyanate, 100 mM Tris·CI, pH 7.0) 
Lysate Wash 
Dilution Solution 
2X Binding Solution 
Wash Solution 112 
THE RNA Storage Solution (1 mM Sodium Citrate, pH 6.4) 
20 mg Oligo (dT) Cellulose 
5 M Ammonium Acetate 
Glycogen (5 mg/ml) 
TurboDNA free Kit 
Turbo DNAse (2 Units/ul) 
lOX Turbo DNase buffer 
DNAase Inactivation Reagent 
Nuclease free water 
Message Sensor RT 
lOX RT-PCR Buffer (3mM MgCI at IX) 
2,5mM dNTP Mix (2.5 mM each dNTP) 
I 0 u/~I RNase Inhibitor 
IM-MLVRT 
I OuM hGAPDH Control j>rimers 
10ng/ul ~I HeLa S3 Control RNA 
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Ambion 
Ambion 
Ambion 
Ambion 
Real Time PCR 
lOX PCR buffer 
(ISm.M MgClzrrris.ClI, KCI, (NH4)2S04; p.H 8.7) 
MgClz 2SmM 
HotStart TAQ Sunits/ul 
PCR primers & Taqman Probes 
DNA plasmid clones· 
d.NTPS IOuM 
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Qiagen 
TIB MolBio! Berlin 
Dr Heather Coleman 
Roche 
APPENDIX III: REAL TIME PCR DATA SETS FOR 3T3 FIBROBLASTS AND RAW · 
MACROPHAGE INFECTIONS with ~50lucgMGFP(BAC-) OVER 30 DAYS 
FIGURE 31: 18S PRIMER SET 
Copy 
Mean of Ct Std Dev of Ct No,per no template 
Sample Repeats Ct value Values values reaction control 
1 1 6.49 6.84 0.41 345,271,432 2,251 
2 6.75 
3 7.29 
5 1 5.46 5.7 0.07 622,039,700 1,859 
2 5.77 
3 6.59 
10 1 6.65 6.71 0.17 369,042,736 1,709 
2 6.9 
3 6.59 
15 1 5.33 5.67 0.24 629,221 ,600 1,547 
2 5.52 
3 5.65 
20 1 6.03 6.03 0.32 525,087,682 1,868 
2 5.86 
3 5.66 
25 1 5.31 5.11 3.44 840,694,379 1,661 
2 5.28 
3 4.74 
30 1 7.71 9.6 0.04 83,935,291 2,354 
2 7.52 
3 13.58 
163 
Figgre 31: ORF 9 PRIMER SET 
Copy 
Mean of Ct Std Dev of Ct No,per no template 
Sample Repeats Ct value Values values reaction control 
1 1 25.22 25.24 0.03 1 0 
2 80 
3 25.23 
5 1 24.32 24.26 0.07 3 0 
2 24.28 
3 24.19 
10 1 24.75 24.72 0.04 2 0 
2 24.73 
3 24.67 
15 1 25.84 25.7 4.95 0 0 
2 25.73 
3 25.58 
20 1 33.83 34.6 0 0 
2 34.55 
3 35.65 
25 1 33.07 33.4 0.29 0 0 
2 33.57 
3 33.56 
30 1 38.13 36.72 1.24 0 0 
2 35.8 
3 36.23 
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FIGURE 31: M2 PRIMER SET 
Copy 
Mean of Ct Std Dev of Ct No,per no template 
sample Repeats Ct value Values values reaction control 
1 1 29.47 29.39 0.07 1167 0 
2 29.35 
3 29.57 
5 1 29.73 29.73 0.12 921 4 
2 29.67 
3 29.87 
10 1 30.9 30.9 0.14 412 1 
2 30.76 
3 31.03 
15 1 31.8 31.69 0.17 239 1 
2 31.85 
3 31.83 
20 1 31.5 31.5 0 273 1 
2 31.46 
3 31.7 
25 1 27.99 28.01 0.08 3020 0 
2 27.94 
3 28.1 
30 1 32.67 32.46 0 140 0 
2 32.29 
3 32.47 
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FIGURE 32: M2 PRIMER SET 
Copy 
Mean of Ct Std Dev of Ct No,per no template 
sample repeats Ct value Values values reaction controls 
1 1 22.68 21.37 0.08 7319 0 
2 22-Jan 
3 22.53 
5 1 20.69 19.99 0.02 26093 1 
2 20.72 
3 20.71 
10 1 21.39 19.55 0.2 17160 0 
2 21.49 
3 21.11 
15 1 22.68 20.26 0.01 6965 2 
2 22.67 
3 22.69 
20 1 23.79 23.05 0.14 3444 2 
2 23.82 
3 23.57 
25 1 21.89 19.58 0.007 11781 
2 21.96 
3 21.82 
30 1 25.81 25.9 0.02 846 0 
2 25.82 
3 25.83 
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FIGURE 32: ORF73 PRIMER SET 
Copy 
Mean of Ct Std Dev of Ct No,per no template 
sample repeats Ct value Values values reaction control 
1 1 21.37· 21.37 0.04 278 0 
2 21.33 
3 21.42 
5 1 19.83 19.99 0.14 729 0 
2 20.11 
3 20.02 
10 1 19.55 19.55 0.09 989 0 
2 19.64 
3 19.46 
15 1 20.26 20.26 0.08 600 0 
2 20.34 
3 20.18 
20 23.08 23.05 0.07 85 0 
2 23.1 
3 22.98 
25 1 19.47 19.58 0.11 971 0 
2 19.58 
3 19.68 
30 1 25.83 25.9 0.14 11 0 
2 26.06 
3 25.8 
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FIGURE 32: ORF9 PRMER SET 
Copy 
Mean of Ct Std Dev of Ct No.per 
sample repeats Ct value Values values reaction Control 
1 1 31.76 32.14 0.46 2 0 
2 32.06 
3 35.72 
5 1 28.08 28.04 0.06 36 0 
2 27.97 
3 32.01 
10 1 31 .98 32.03 0.17 2 0 
2 32.22 
3 28.07 
15 1 33.59 33.7 1.22 0 0 
2 32.54 
3 31.89 
20 1 34.89 34.17 1.1 0 0 
2 34.72 
3 34.97 
25 1 30.13 30.45 0.18 6 0 
2 30.66 
3 32.91 
30 1 33.95 33.98 0.28 0 0 
2 33.26 
3 34.77 
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FIGURE 32: 18S PRIMER SET 
Copy 
Mean of Ct Std Dev of Ct No,per no template 
sample repeats Ct value Values values reaction control 
1 1 20.7 20.47 0.05 37,845,419 35,459 
2 20.73 
3 20.83 
5 1 19.17 19.29 0.26 99,844,656 1,11 6 
2 19.59 1,116 
3 19.19 
10 1 20.71 20.07 0.02 39,920,883 842 
2 20.68 
3 20.72 
15 1 21.71 21.6 0.17 22,231,380 98 
2 20.68 
3 20 
20 1 12 12.19 0.19 1,845 
2 12.38 1.0095E+l0 
3 12.2 
25 1 12.86 12.54 0.45 
2 12.73 8042930053 0 
3 12.03 
30 1 12.28 12.39 0.26 
2 12.69 8866986505 0 
3 12.23 
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